chr6:43770211:> Detail (hg38)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr6:43,737,948-43,754,224 |
hg38 | chr6:43,770,211-43,786,487 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.191 | squamous cell carcinoma | Expression of vascular endothelial growth factor (VEGF) in patients with oral sq... | BeFree,CTD_human,GAD,LHGDN | 24833243 | Detail |
0.191 | squamous cell carcinoma | WISP-1 a novel angiogenic regulator of the CCN family promotes oral squamous cel... | BeFree,CTD_human,GAD,LHGDN | 25738362 | Detail |
0.191 | squamous cell carcinoma | Increased TGFβ signaling and VEGF expression were observed in Col7 KD xenografts... | BeFree,CTD_human,GAD,LHGDN | 26476432 | Detail |
0.009 | Carcinoma, Transitional Cell | Gene expression of STAT3, NF-κB, TGFβ1, cyclin D1 and VEGFA was measured by quan... | BeFree,LHGDN | 24448750 | Detail |
<0.001 | carcinosarcoma | NA | BeFree | Detail | |
0.001 | Cardiomyopathy, Dilated | Autoantibodies in dilated cardiomyopathy induce vascular endothelial growth fact... | BeFree | 26248134 | Detail |
0.011 | Cardiovascular Diseases | The high comorbidity between cardiovascular disease and major depression disorde... | BeFree,GAD,LHGDN | 24718046 | Detail |
0.011 | Cardiovascular Diseases | However, until now only a handful number of genetic variants were reported to be... | BeFree,GAD,LHGDN | 25169573 | Detail |
<0.001 | carotid stenosis | In this study, production of elastase, interleukin (IL)-8 and vascular endotheli... | BeFree | 25893670 | Detail |
0.002 | Neoplastic Cell Transformation | NA | GAD | Detail | |
<0.001 | intracranial aneurysm | NA | BeFree | Detail | |
0.003 | Intracranial Arteriovenous Malformation | NA | LHGDN | Detail | |
0.004 | cerebral infarction | Transplantation of BMSCs stably expressing mutant HIF1α significantly improved m... | BeFree | 25270619 | Detail |
0.003 | brain ischemia | NA | BeFree,GAD | Detail | |
0.008 | Malignant tumor of cervix | Effects of VEGF suppression by small hairpin RNA interference combined with radi... | BeFree | 25061734 | Detail |
0.008 | Malignant tumor of cervix | Molecular regulation of cervical cancer growth and invasion by VEGFa. | BeFree | 25135429 | Detail |
0.008 | Malignant tumor of cervix | To investigate the effect of recombinant human p53 adenovirus injection combined... | BeFree | 25855930 | Detail |
0.008 | Uterine Cervical Neoplasm | NA | GAD,LHGDN | Detail | |
<0.001 | Chest Pain | NA | BeFree | Detail | |
<0.001 | cholecystitis | NA | BeFree | Detail | |
<0.001 | cholera | NA | BeFree | Detail | |
0.003 | cholesteatoma | NA | LHGDN | Detail | |
<0.001 | Chondromatosis, Synovial | Expressions of TGF-β1, TGF-β3, FGF-2, Sox9, Wnt-4, Foxc2, and VEGF-A mRNA were s... | BeFree | 25742744 | Detail |
0.006 | chondrosarcoma | MicroRNA regulates vascular endothelial growth factor expression in chondrosarco... | BeFree,LHGDN | 25106798 | Detail |
0.006 | chondrosarcoma | CCL5 increased VEGF expression and also promoted chondrosarcoma conditional medi... | BeFree,LHGDN | 25301739 | Detail |
0.006 | chondrosarcoma | In this study, CCL5 increased VEGF expression and also promoted chondrosarcoma m... | BeFree,LHGDN | 25444917 | Detail |
0.006 | chondrosarcoma | Basic fibroblast growth factor induces VEGF expression in chondrosarcoma cells a... | BeFree,LHGDN | 25735814 | Detail |
0.002 | chorioamnionitis | NA | GAD | Detail | |
<0.001 | choriocarcinoma | We examined the growth-modulatory effects of different concentrations of heparin... | BeFree | 25503134 | Detail |
<0.001 | Congenital chromosomal disease | NA | BeFree | Detail | |
0.120 | Bronchitis, Chronic | NA | BeFree,CTD_human | Detail | |
<0.001 | colitis | We investigated whether vascular endothelial growth factor (VEGF) signaling via ... | BeFree | 25797700 | Detail |
0.003 | ulcerative colitis | Potential dual immunomodulatory role of VEGF in ulcerative colitis and colorecta... | BeFree,GAD | 25076849 | Detail |
0.239 | Colonic Neoplasms | Our results showed that biglycan overexpression notably up-regulated the levels ... | BeFree,CTD_human,GAD,LHGDN,RGD | 25371074 | Detail |
0.035 | colorectal carcinoma | Constant development of chemotherapy and more recently the introduction of VEGF-... | BeFree | 24727985 | Detail |
0.035 | colorectal carcinoma | Potential dual immunomodulatory role of VEGF in ulcerative colitis and colorecta... | BeFree | 25076849 | Detail |
0.035 | colorectal carcinoma | We analyzed VEGF (-2578C>A, -1498C>T, -1154G>A, -634C>G, +936C>T) and eNOS (+894... | BeFree | 25079441 | Detail |
0.035 | colorectal carcinoma | Association between EGF and VEGF functional polymorphisms and sporadic colorecta... | BeFree | 25117311 | Detail |
0.035 | colorectal carcinoma | These results indicate that alternative splicing of an RNA binding protein can r... | BeFree | 25224594 | Detail |
0.035 | colorectal carcinoma | VEGF IHC positivity was significantly more common in patients with high expressi... | BeFree | 25422250 | Detail |
0.035 | colorectal carcinoma | Interplay between 3'-UTR polymorphisms in the vascular endothelial growth factor... | BeFree | 25423914 | Detail |
0.035 | colorectal carcinoma | The molecular targets of CRC include at least two important cell surface recepto... | BeFree | 25561783 | Detail |
0.035 | colorectal carcinoma | We found that FIH-1 was able to inhibit HIF1α mediated transcription of GLUT1 an... | BeFree | 25602156 | Detail |
0.035 | colorectal carcinoma | To characterize the population pharmacokinetics of bevacizumab, its binding prop... | BeFree | 25687989 | Detail |
0.035 | colorectal carcinoma | Serum cytokine levels in patients with colorectal cancers according to tumor sta... | BeFree | 25713884 | Detail |
0.035 | colorectal carcinoma | Furthermore, the expression level of excision repair cross-complementation group... | BeFree | 26031756 | Detail |
0.055 | Colorectal Neoplasms | NA | BeFree,GAD,LHGDN | Detail | |
0.002 | Connective Tissue Diseases | NA | GAD | Detail | |
<0.001 | Corneal Diseases | NA | BeFree | Detail | |
0.018 | Coronary Arteriosclerosis | Dysregulated miR-361-5p/VEGF axis in the plasma and endothelial progenitor cells... | BeFree,GAD | 24865854 | Detail |
0.018 | Coronary Arteriosclerosis | We aimed to investigate the correlation between the levels of circulating miR-21... | BeFree,GAD | 25575606 | Detail |
0.018 | Coronary Arteriosclerosis | Association between VEGF polymorphisms (936c/t, -460t/c and -634g/c) with haplot... | BeFree,GAD | 25755796 | Detail |
0.023 | Coronary heart disease | Dysregulated miR-361-5p/VEGF axis in the plasma and endothelial progenitor cells... | BeFree,GAD,LHGDN | 24865854 | Detail |
0.023 | Coronary heart disease | We aimed to investigate the correlation between the levels of circulating miR-21... | BeFree,GAD,LHGDN | 25575606 | Detail |
0.023 | Coronary heart disease | Association between VEGF polymorphisms (936c/t, -460t/c and -634g/c) with haplot... | BeFree,GAD,LHGDN | 25755796 | Detail |
<0.001 | Crohn Disease | NA | BeFree | Detail | |
<0.001 | adenoid cystic carcinoma | We retrieved 27 cases of 1-4-cm-sized adenoid cystic carcinomas (ACCs) arising f... | BeFree | 24456477 | Detail |
<0.001 | cystadenoma | NA | BeFree | Detail | |
<0.001 | Cystadenoma, Mucinous | NA | BeFree | Detail | |
<0.001 | cystic fibrosis | NA | BeFree | Detail | |
<0.001 | cystitis | NA | BeFree | Detail | |
0.004 | Cyst | NA | BeFree,LHGDN | Detail | |
0.003 | Cessation of life | NA | LHGDN | Detail | |
0.080 | Pressure Ulcer | NA | BeFree,RGD | Detail | |
0.006 | Dementia, Vascular | Genes that were upregulated in VaD were MMP9 and VEGFA. | BeFree,GAD,LHGDN | 25024308 | Detail |
<0.001 | Dengue Fever | NA | BeFree | Detail | |
0.001 | Mental Depression | Furthermore, our data also demonstrate that other factors than a diagnosis of de... | BeFree | 24636631 | Detail |
0.001 | Mental Depression | A higher VEGF concentration may play a potentially significant role in the patho... | BeFree | 24718046 | Detail |
0.002 | depressive disorder | Furthermore, our data also demonstrate that other factors than a diagnosis of de... | BeFree | 24636631 | Detail |
0.002 | depressive disorder | A higher VEGF concentration may play a potentially significant role in the patho... | BeFree | 24718046 | Detail |
<0.001 | dermatitis herpetiformis | NA | BeFree | Detail | |
0.004 | Dermatitis, Atopic | NA | BeFree,LHGDN | Detail | |
0.120 | contact dermatitis | NA | CTD_human | Detail | |
0.003 | dermatomyositis | NA | LHGDN | Detail | |
<0.001 | scleroderma | NA | BeFree | Detail | |
0.011 | Diabetes | VEGF-A inhibition ameliorates podocyte apoptosis via repression of activating pr... | BeFree | 25572464 | Detail |
0.011 | Diabetes | We have previously demonstrated that downregulation of miR-200b increases VEGF, ... | BeFree | 25884496 | Detail |
0.022 | diabetes mellitus | VEGF genetic polymorphisms may contribute to the risk of diabetic nephropathy in... | BeFree,GAD,LHGDN | 25184149 | Detail |
0.022 | diabetes mellitus | VEGF-A inhibition ameliorates podocyte apoptosis via repression of activating pr... | BeFree,GAD,LHGDN | 25572464 | Detail |
0.022 | diabetes mellitus | We have previously demonstrated that downregulation of miR-200b increases VEGF, ... | BeFree,GAD,LHGDN | 25884496 | Detail |
0.200 | Diabetes Mellitus, Experimental | NA | CTD_human,RGD | Detail | |
0.014 | Diabetes Mellitus, Insulin-Dependent | Placental vascular endothelial growth factor expression in pregnancies complicat... | BeFree,GAD | 25179090 | Detail |
0.181 | Diabetes Mellitus, Non-Insulin-Dependent | Association of polymorphisms in the vascular endothelial growth factor gene and ... | BeFree,CTD_human,GAD | 24534217 | Detail |
0.181 | Diabetes Mellitus, Non-Insulin-Dependent | In addition, VEGF serum levels were analyzed in 98 subjects with type 2 diabetes... | BeFree,CTD_human,GAD | 25128838 | Detail |
0.181 | Diabetes Mellitus, Non-Insulin-Dependent | We have previously confirmed the associations of genetic variants in HHEX, CDKAL... | BeFree,CTD_human,GAD | 25587982 | Detail |
0.083 | Diabetic Angiopathies | Vascular endothelial growth factor A (VEGF) and its receptor KDR play central ro... | BeFree,GAD,RGD | 25128838 | Detail |
0.007 | Diabetic Neuropathies | NA | BeFree,GAD,LHGDN | Detail | |
0.210 | diabetic retinopathy | Association of polymorphisms in the vascular endothelial growth factor gene and ... | BeFree,CTD_human,GAD,LHGDN | 24534217 | Detail |
0.210 | diabetic retinopathy | To investigate how VEGF-634G/C and VEGF-460C/T SNPs are related to diabetic reti... | BeFree,CTD_human,GAD,LHGDN | 25217793 | Detail |
0.210 | diabetic retinopathy | Ocular anti-VEGF therapy is highly effective for treating a subset of patients w... | BeFree,CTD_human,GAD,LHGDN | 25457617 | Detail |
0.210 | diabetic retinopathy | We recently demonstrated that 12/15-lipoxygenase (LOX) derived metabolites, hydr... | BeFree,CTD_human,GAD,LHGDN | 25562624 | Detail |
0.210 | diabetic retinopathy | Glucose-induced augmented vascular endothelial growth factor (VEGF) production i... | BeFree,CTD_human,GAD,LHGDN | 25884496 | Detail |
0.210 | diabetic retinopathy | Moreover the study was intended to evaluate the role of VEGF gene single nucleot... | BeFree,CTD_human,GAD,LHGDN | 25956512 | Detail |
<0.001 | Camurati-Engelmann Syndrome | NA | BeFree | Detail | |
0.083 | DiGeorge syndrome | NA | BeFree,GAD,MGD | Detail | |
<0.001 | diphtheria | NA | BeFree | Detail | |
0.003 | diverticulitis | NA | LHGDN | Detail | |
0.003 | Down syndrome | NA | BeFree,LHGDN | Detail | |
0.083 | duodenal ulcer | NA | BeFree,GAD,RGD | Detail | |
<0.001 | Dyskinetic syndrome | NA | BeFree | Detail | |
0.004 | eclampsia | Investigation of polymorphisms in pre-eclampsia related genes VEGF and IL1A. | BeFree | 25322977 | Detail |
0.004 | eclampsia | Decreased placental miR-126 expression and vascular endothelial growth factor le... | BeFree | 25341970 | Detail |
<0.001 | Eczema | NA | BeFree | Detail | |
0.003 | Edema | NA | LHGDN | Detail | |
<0.001 | Localized edema | NA | BeFree | Detail | |
0.005 | Filarial Elephantiases | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Empyema | NA | BeFree | Detail | |
0.081 | Experimental Autoimmune Encephalomyelitis | NA | BeFree,RGD | Detail | |
0.131 | Endometrial Neoplasms | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
0.155 | endometriosis | Role of vascular endothelial growth factor polymorphisms (-2578C>A, -460 T>C, -1... | BeFree,GAD,LHGDN,RGD | 25255852 | Detail |
0.155 | endometriosis | p27kip1 overexpression regulates VEGF expression, cell proliferation and apoptos... | BeFree,GAD,LHGDN,RGD | 25534318 | Detail |
0.003 | Enterocolitis | NA | BeFree,LHGDN | Detail | |
<0.001 | Ependymoma | NA | BeFree | Detail | |
0.120 | Epilepsy, Temporal Lobe | NA | CTD_human | Detail | |
<0.001 | erythema multiforme | NA | BeFree | Detail | |
0.003 | Esophageal and Gastric Varices | NA | LHGDN | Detail | |
0.013 | Esophageal Neoplasms | Role of +405C>G and +936C>T polymorphisms of the vascular endothelial growth fac... | BeFree,GAD,LHGDN | 25640399 | Detail |
<0.001 | Esophageal Varices | NA | BeFree | Detail | |
0.005 | Disorder of eye | NA | BeFree,GAD | Detail | |
0.002 | Eye Diseases, Hereditary | NA | GAD | Detail | |
<0.001 | Eye Infections | NA | BeFree | Detail | |
<0.001 | Fatty Liver | NA | BeFree | Detail | |
0.002 | Femur Head Necrosis | NA | GAD | Detail | |
<0.001 | Fenestration (morphologic abnormality) | NA | BeFree | Detail | |
0.002 | Fetal Diseases | NA | GAD | Detail | |
0.002 | Fetal Membranes, Premature Rupture | NA | GAD | Detail | |
0.005 | fibrosarcoma | NA | BeFree,LHGDN | Detail | |
0.008 | Fibrosis | NA | LHGDN | Detail | |
<0.001 | Gall Bladder Diseases | NA | BeFree | Detail | |
<0.001 | ganglioneuroma | NA | BeFree | Detail | |
<0.001 | Gangrene | NA | BeFree | Detail | |
0.003 | gastritis | NA | BeFree,GAD | Detail | |
<0.001 | Gastritis, Atrophic | NA | BeFree | Detail | |
<0.001 | gastroesophageal reflux disease | NA | BeFree | Detail | |
0.081 | glaucoma | NA | BeFree,RGD | Detail | |
<0.001 | Glaucoma, Neovascular | NA | BeFree | Detail | |
0.042 | Glioma | However, caution is required because the correlation was weak and there was a la... | BeFree,GAD,LHGDN | 24781871 | Detail |
0.042 | Glioma | Using the World Health Organization grade, histological subtype, and molecular v... | BeFree,GAD,LHGDN | 24874469 | Detail |
0.042 | Glioma | Interferon-β inhibits glioma angiogenesis through downregulation of vascular end... | BeFree,GAD,LHGDN | 25175315 | Detail |
0.042 | Glioma | Although anti-VEGF therapy is widely used in high-grade gliomas, no predictor of... | BeFree,GAD,LHGDN | 25488073 | Detail |
0.042 | Glioma | We show here that a strong link exists among SRPK1, Akt, eIF4E, HIF-1, and VEGF ... | BeFree,GAD,LHGDN | 25833691 | Detail |
0.042 | Glioma | We found that the glioma tissue was positive for A2B5 (Glial precursors ganglios... | BeFree,GAD,LHGDN | 25879429 | Detail |
0.042 | Glioma | By using gene silencing as an experimental approach we found that MMP14 knockdow... | BeFree,GAD,LHGDN | 26052095 | Detail |
0.006 | IgA glomerulonephritis | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | membranous glomerulonephritis | NA | BeFree | Detail | |
<0.001 | Nodular glomerulosclerosis | NA | BeFree | Detail | |
<0.001 | goiter | NA | BeFree | Detail | |
0.003 | Graft-vs-Host Disease | NA | BeFree,GAD | Detail | |
0.003 | Granuloma | NA | LHGDN | Detail | |
0.003 | granulosa cell tumor | NA | BeFree,LHGDN | Detail | |
<0.001 | Graves Disease | NA | BeFree | Detail | |
<0.001 | gynecomastia | NA | BeFree | Detail | |
<0.001 | Hamartoma | NA | BeFree | Detail | |
<0.001 | Hay fever | NA | BeFree | Detail | |
0.125 | Head and Neck Neoplasms | NA | CTD_human,GAD | Detail | |
<0.001 | Headache | NA | BeFree | Detail | |
<0.001 | cardiac arrest | NA | BeFree | Detail | |
0.126 | congenital heart defects | NA | BeFree,CTD_human,GAD | Detail | |
0.120 | Heart Diseases | NA | BeFree,CTD_human | Detail | |
0.127 | Heart failure | Cardiomyocyte-specific overexpression of the α1A-adrenergic receptors resulted i... | BeFree,CTD_human,GAD | 26338300 | Detail |
0.003 | congestive heart failure | Cardiomyocyte-specific overexpression of the α1A-adrenergic receptors resulted i... | BeFree | 26338300 | Detail |
<0.001 | Heart Septal Defects | NA | BeFree | Detail | |
0.005 | Ventricular Septal Defects | NA | BeFree,GAD,LHGDN | Detail | |
0.004 | hemangioma | NA | BeFree | Detail | |
0.122 | Hemangiosarcoma | NA | BeFree,CTD_human | Detail | |
<0.001 | Hematological Disease | NA | BeFree | Detail | |
0.005 | Hemorrhage | NA | LHGDN | Detail | |
0.003 | Severe Dengue | NA | LHGDN | Detail | |
<0.001 | hepatitis B | i) Serum VEGF levels were higher in patients with progressive disease than those... | BeFree | 25862879 | Detail |
0.003 | hepatitis C | i) Serum VEGF levels were higher in patients with progressive disease than those... | BeFree,LHGDN | 25862879 | Detail |
<0.001 | Herpes NOS | NA | BeFree | Detail | |
0.001 | Herpes Simplex Infections | NA | BeFree | Detail | |
<0.001 | Keratitis, Herpetic | NA | BeFree | Detail | |
<0.001 | Herpesviridae Infections | NA | BeFree | Detail | |
0.004 | Von Hippel-Lindau syndrome | We performed immunohistochemical studies on 23 hemangioblastomas, 13 meningiomas... | BeFree | 25310734 | Detail |
0.001 | HIV Infections | NA | BeFree | Detail | |
0.005 | Hodgkin Disease | NA | LHGDN | Detail | |
<0.001 | Huntington disease | Evaluating the SERCA2 and VEGF mRNAs as Potential Molecular Biomarkers of the On... | BeFree | 25915065 | Detail |
<0.001 | hydronephrosis | Expression of VEGF in neonatal urinary obstruction: does expression of VEGF pred... | BeFree | 25951999 | Detail |
<0.001 | Hydrothorax | Diagnostic values of vascular endothelial growth factor and epidermal growth fac... | BeFree | 25635424 | Detail |
<0.001 | Hypercholesterolemia | NA | BeFree | Detail | |
0.003 | hyperglycemia | The sEng, sFlt-1, and interleukin-6 were up-regulated, whereas the VEGF and PlGF... | BeFree | 24793974 | Detail |
0.003 | hyperglycemia | Expression of FAM18B in primary human retinal microvascular endothelial cells (H... | BeFree | 25221423 | Detail |
<0.001 | hyperinsulinism | NA | BeFree | Detail | |
<0.001 | Hyperlipidemia | NA | BeFree | Detail | |
0.002 | Hyperparathyroidism, Secondary | NA | GAD | Detail | |
0.003 | Hyperplasia | NA | LHGDN | Detail | |
0.015 | Hypertensive disease | Increased angiogenic factors [vascular endothelial growth factor-A (VEGF-A) and ... | BeFree,GAD,LHGDN | 24786777 | Detail |
0.015 | Hypertensive disease | Vascular endothelial growth factor (VEGF) is relevant for healthy pregnancy, and... | BeFree,GAD,LHGDN | 25234518 | Detail |
0.015 | Hypertensive disease | Vascular Endothelial Growth Factor A c.*237C>T polymorphism is associated with b... | BeFree,GAD,LHGDN | 25617075 | Detail |
0.121 | Hypertension, Portal | NA | BeFree,CTD_human | Detail | |
0.005 | pulmonary hypertension | Given these results, here we analyzed the effect of HEXIM1 on the expression of ... | BeFree,LHGDN | 25301555 | Detail |
0.004 | hypoglycemia | NA | BeFree,LHGDN | Detail | |
<0.001 | hypothyroidism | NA | BeFree | Detail | |
0.001 | Angioimmunoblastic Lymphadenopathy | NA | BeFree | Detail | |
0.005 | Immunologic Deficiency Syndromes | Injection of only 10(4) hESC-derived SSEA-1(+) /MesP1(+) cells, or their progeny... | BeFree | 25069679 | Detail |
0.003 | infertility | NA | LHGDN | Detail | |
0.002 | Female infertility | NA | GAD | Detail | |
0.142 | Inflammation | NA | CTD_human,GAD,LHGDN | Detail | |
0.001 | Inflammatory Bowel Diseases | NA | BeFree | Detail | |
<0.001 | intermittent claudication | NA | BeFree | Detail | |
<0.001 | Intestinal Polyps | NA | BeFree | Detail | |
0.024 | ischemia | Collectively, we discovered a miR-361-5p/VEGF-dependent regulation that could he... | BeFree | 24865854 | Detail |
<0.001 | arthropathy | NA | BeFree | Detail | |
0.002 | Keloid | Upregulated periostin promotes angiogenesis in keloids through activation of the... | BeFree | 25369801 | Detail |
<0.001 | keratitis | NA | BeFree | Detail | |
0.007 | Kidney Diseases | NA | BeFree,GAD | Detail | |
0.001 | Kidney Failure, Acute | NA | BeFree | Detail | |
0.006 | Kidney Neoplasm | NA | BeFree,GAD | Detail | |
0.002 | Premature Obstetric Labor | NA | GAD | Detail | |
0.002 | Laryngeal neoplasm | NA | GAD | Detail | |
0.120 | Learning Disorders | NA | CTD_human | Detail | |
<0.001 | Leg Ulcer | NA | BeFree | Detail | |
0.008 | Fibroid Tumor | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | leiomyosarcoma | In line, cell growth in leiomyosarcoma cell lines remained unchanged upon PTK787... | BeFree | 25340839 | Detail |
0.024 | leukemia | NA | BeFree,LHGDN | Detail | |
0.013 | chronic lymphocytic leukemia | Vascular endothelial growth factor A (VEGFA) gene polymorphisms have an impact o... | BeFree,GAD,LHGDN | 24971577 | Detail |
0.013 | chronic lymphocytic leukemia | Clinical relevance of vascular endothelial growth factor type A (VEGFA) and VEGF... | BeFree,GAD,LHGDN | 25488616 | Detail |
<0.001 | Acute Erythroblastic Leukemia | NA | BeFree | Detail | |
0.002 | Acute lymphocytic leukemia | NA | BeFree | Detail | |
<0.001 | Leukemia, Lymphocytic, Acute, L1 | NA | BeFree | Detail | |
<0.001 | acute monocytic leukemia | NA | BeFree | Detail | |
0.023 | Leukemia, Myelocytic, Acute | This was associated with concomitant attenuation of FoxM1 and its downstream gen... | BeFree,GAD,LHGDN | 25179295 | Detail |
0.023 | Leukemia, Myelocytic, Acute | Heparan sulfate D-glucosaminyl 3-O-sulfotransferase-3B1 (HS3ST3B1) promotes angi... | BeFree,GAD,LHGDN | 25536282 | Detail |
0.121 | myeloid leukemia | NA | BeFree,CTD_human | Detail | |
0.016 | Myeloid Leukemia, Chronic | In conclusion, CML in blast crisis had increased levels of CECs and VEGF gene ex... | BeFree,GAD,LHGDN | 25831205 | Detail |
<0.001 | Leukemia, Plasma Cell | NA | BeFree | Detail | |
<0.001 | prolymphocytic leukemia | NA | BeFree | Detail | |
<0.001 | acute promyelocytic leukemia | NA | BeFree | Detail | |
<0.001 | Leukemia, T-Cell | NA | BeFree | Detail | |
<0.001 | Adult T-Cell Lymphoma/Leukemia | NA | BeFree | Detail | |
<0.001 | Leukemia, T-Cell, Chronic | NA | BeFree | Detail | |
<0.001 | Leukomalacia, Periventricular | These findings provide an animal model that reproduces the temporal and spatial ... | BeFree | 25689256 | Detail |
0.138 | liver cirrhosis | i) Serum VEGF levels were higher in patients with progressive disease than those... | BeFree,CTD_human,GAD,LHGDN | 25862879 | Detail |
0.120 | Liver Cirrhosis, Experimental | NA | CTD_human | Detail | |
<0.001 | Liver diseases | NA | BeFree | Detail | |
0.008 | Liver neoplasms | NA | BeFree,GAD | Detail | |
0.122 | Lung diseases | NA | BeFree,CTD_human | Detail | |
0.014 | Chronic Obstructive Airway Disease | NA | BeFree,GAD,LHGDN | Detail | |
0.033 | Lung Neoplasms | The effects of recombinant VEGF and its blockade on lung tumor cell proliferatio... | BeFree,LHGDN | 25889301 | Detail |
0.006 | Lupus Erythematosus, Systemic | Serum VEGF level in the active SLE group was significantly higher than that in t... | BeFree,GAD,LHGDN | 25359881 | Detail |
0.006 | Lupus Erythematosus, Systemic | We sought to determine the relevance of these findings to autoimmunity because e... | BeFree,GAD,LHGDN | 25475856 | Detail |
<0.001 | lupus nephritis | NA | BeFree | Detail | |
<0.001 | Lymphangiectasis | NA | BeFree | Detail | |
<0.001 | lymphangioma | NA | BeFree | Detail | |
0.015 | Lymphatic Metastasis | Lymphangiogenesis is actively contributed to lymphatic metastasis in gastric can... | BeFree,GAD,LHGDN | 25444928 | Detail |
<0.001 | lymphedema | NA | BeFree | Detail | |
0.020 | lymphoma | In summary, overexpression of VEGF in lymphoma tissue represents a promising pot... | BeFree,GAD,LHGDN | 25810565 | Detail |
<0.001 | Lymphoma, Follicular | NA | BeFree | Detail | |
0.017 | Lymphoma, Non-Hodgkin | VEGF overexpression is a valuable prognostic factor for non-Hodgkin's lymphoma e... | BeFree,GAD,LHGDN | 25810565 | Detail |
<0.001 | lymphopenia | NA | BeFree | Detail | |
0.005 | macular degeneration | Ocular anti-VEGF therapy is highly effective for treating a subset of patients w... | BeFree | 25457617 | Detail |
0.002 | Macular Edema, Cystoid | Conbercept (KH902), a novel recombinant, soluble vascular endothelial growth fac... | BeFree | 25737631 | Detail |
0.002 | Macular Edema, Cystoid | The aqueous humor levels of IL-1β, IL-6, IL-8, MCP-1, IP-10, and VEGF were close... | BeFree | 25923230 | Detail |
<0.001 | macular holes | NA | BeFree | Detail | |
0.003 | Malaria, Cerebral | NA | LHGDN | Detail | |
0.029 | Malignant neoplasm of stomach | In addition, ramucirumab, a monoclonal antibody targeting vascular endothelial g... | BeFree,GAD | 24744582 | Detail |
0.029 | Malignant neoplasm of stomach | We performed a meta-analysis of individual patient data from six randomized phas... | BeFree,GAD | 25012543 | Detail |
0.029 | Malignant neoplasm of stomach | Overexpression of different PFKFB in pancreatic and gastric cancer cells under h... | BeFree,GAD | 25320508 | Detail |
0.029 | Malignant neoplasm of stomach | However, ramucirumab that targets VEGF receptor-2 prolonged overall survival in ... | BeFree,GAD | 25320512 | Detail |
0.029 | Malignant neoplasm of stomach | Reduced miR-126 expression facilitates angiogenesis of gastric cancer through it... | BeFree,GAD | 25428912 | Detail |
0.029 | Malignant neoplasm of stomach | Lymphangiogenesis is actively contributed to lymphatic metastasis in gastric can... | BeFree,GAD | 25444928 | Detail |
0.029 | Malignant neoplasm of stomach | miR-874 functions as a tumor suppressor by inhibiting angiogenesis through STAT3... | BeFree,GAD | 25596740 | Detail |
0.029 | Malignant neoplasm of stomach | Gastric cancer-associated enhancement of von Willebrand factor is regulated by v... | BeFree,GAD | 25886574 | Detail |
<0.001 | medulloblastoma | Pancreatic endoplasmic reticulum kinase activation promotes medulloblastoma cell... | BeFree | 25794107 | Detail |
0.045 | melanoma | Previous studies indicate that fibroblast growth factors (b-FGF/FGF-2), an angio... | BeFree,LHGDN | 25597785 | Detail |
0.045 | melanoma | Induction of Vasculogenic Mimicry Overrides VEGF-A Silencing and Enriches Stem-l... | BeFree,LHGDN | 25769726 | Detail |
0.045 | melanoma | Clinical and prognostic significance of survivin, AKT and VEGF in primary mucosa... | BeFree,LHGDN | 25862867 | Detail |
0.045 | melanoma | Simultaneous chemotherapy with vascular endothelial growth factor (VEGF) inhibit... | BeFree,LHGDN | 25867272 | Detail |
0.045 | melanoma | The expression of PRRs (Toll-like receptors and melanoma differentiation-associa... | BeFree,LHGDN | 26047816 | Detail |
<0.001 | Melanoma, Experimental | NA | BeFree | Detail | |
0.120 | Memory Disorders | NA | CTD_human | Detail | |
<0.001 | multiple endocrine neoplasia type 2A | NA | BeFree | Detail | |
0.007 | meningioma | Hypoxia inducible factor-1 is involved in growth factor, glucocorticoid and hypo... | BeFree,LHGDN | 24980036 | Detail |
<0.001 | Menstruation, Retrograde | NA | BeFree | Detail | |
<0.001 | Mesothelioma | NA | BeFree | Detail | |
0.003 | Metaplasia | NA | LHGDN | Detail | |
0.001 | mitral valve stenosis | NA | BeFree | Detail | |
<0.001 | Mixed Salivary Gland Tumor | NA | BeFree | Detail | |
<0.001 | Monoclonal Gammopathy of Undetermined Significance | NA | BeFree | Detail | |
0.009 | Mouth Neoplasms | NA | GAD | Detail | |
<0.001 | Moyamoya disease | NA | BeFree | Detail | |
0.017 | Mucocutaneous Lymph Node Syndrome | NA | BeFree,GAD,LHGDN | Detail | |
0.038 | multiple myeloma | We demonstrated increased expression of eIF4GI in myeloma cells and its attenuat... | BeFree,GAD,LHGDN | 24815186 | Detail |
0.038 | multiple myeloma | Our data suggest that mTOR inhibition and silencing of VEGF expression is associ... | BeFree,GAD,LHGDN | 24903015 | Detail |
0.038 | multiple myeloma | By using global proteomic and transcriptomic profiling on melphalan sensitive an... | BeFree,GAD,LHGDN | 25769101 | Detail |
0.001 | multiple sclerosis | NA | BeFree | Detail | |
0.002 | Musculoskeletal Diseases | NA | GAD | Detail | |
<0.001 | myelofibrosis | NA | BeFree | Detail | |
0.011 | Myeloproliferative disease | NA | BeFree,LHGDN | Detail | |
0.018 | myocardial infarction | NA | BeFree,GAD | Detail | |
0.120 | Myocardial Reperfusion Injury | NA | CTD_human | Detail | |
0.003 | myoma | NA | LHGDN | Detail | |
<0.001 | myopia | NA | BeFree | Detail | |
0.003 | Myxoma | NA | BeFree,LHGDN | Detail | |
0.002 | narcolepsy | NA | GAD | Detail | |
0.006 | Nasal Polyps | NA | BeFree,LHGDN | Detail | |
0.002 | Nasopharyngeal Neoplasms | NA | GAD | Detail | |
0.002 | Neoplasm Invasiveness | NA | GAD | Detail | |
0.134 | Neoplasm Recurrence, Local | NA | CTD_human,GAD | Detail | |
0.120 | Neoplasms, Experimental | NA | BeFree,CTD_human | Detail | |
<0.001 | Neoplasms, Vascular Tissue | NA | BeFree | Detail | |
0.140 | Pathologic Neovascularization | NA | CTD_human,GAD,LHGDN | Detail | |
0.003 | nephritis | NA | BeFree,GAD | Detail | |
0.004 | nephroblastoma | The Wilms' tumor gene (WT1) and the vascular endothelial growth factor (VEGF) ge... | BeFree,LHGDN | 25422204 | Detail |
<0.001 | nephrosclerosis | NA | BeFree | Detail | |
0.001 | lipoid nephrosis | NA | BeFree | Detail | |
<0.001 | nephrotic syndrome | NA | BeFree | Detail | |
0.003 | Nerve Degeneration | NA | LHGDN | Detail | |
<0.001 | nervous system disorder | NA | BeFree | Detail | |
<0.001 | Nervous System Neoplasms | NA | BeFree | Detail | |
0.004 | neurilemmoma | NA | BeFree,LHGDN | Detail | |
0.010 | neuroblastoma | Interaction between bone marrow stromal cells and neuroblastoma cells leads to a... | BeFree | 25648303 | Detail |
0.010 | neuroblastoma | Gain- and loss-of-function studies indicated that secretory ITLN1 facilitated th... | BeFree | 25889839 | Detail |
<0.001 | neurofibroma | NA | BeFree | Detail | |
<0.001 | neurofibromatosis 1 | NA | BeFree | Detail | |
<0.001 | Neurofibromatosis 2 | NA | BeFree | Detail | |
0.001 | acoustic neuroma | Interplay between VEGF-A and cMET signaling in human vestibular schwannomas and ... | BeFree | 25692621 | Detail |
0.001 | acoustic neuroma | In conclusion, the results of the present study indicated that VEGF and pro-infl... | BeFree | 25738867 | Detail |
<0.001 | Nodule | NA | BeFree | Detail | |
0.011 | obesity | NA | BeFree,GAD | Detail | |
<0.001 | oligodendroglioma | NA | BeFree | Detail | |
0.006 | Degenerative polyarthritis | We investigated the efficacy of bevacizumab, an antibody against vascular endoth... | BeFree | 25230745 | Detail |
0.006 | Degenerative polyarthritis | Arthritic synovial tissues from patients with rheumatoid arthritis (RA) or osteo... | BeFree | 25483913 | Detail |
0.120 | Osteochondrodysplasias | NA | CTD_human | Detail | |
<0.001 | Synovial osteochondromatosis | Expressions of TGF-β1, TGF-β3, FGF-2, Sox9, Wnt-4, Foxc2, and VEGF-A mRNA were s... | BeFree | 25742744 | Detail |
0.003 | Osteoporosis, Postmenopausal | NA | BeFree,GAD | Detail | |
0.136 | osteosarcoma | Autocrine VEGF/VEGFR1 signaling in a subpopulation of cells associates with aggr... | BeFree,CTD_human,LHGDN | 24759089 | Detail |
0.136 | osteosarcoma | CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angioge... | BeFree,CTD_human,LHGDN | 25330803 | Detail |
0.136 | osteosarcoma | A key role of microRNA-29b in suppression of osteosarcoma cell proliferation and... | BeFree,CTD_human,LHGDN | 25337211 | Detail |
0.136 | osteosarcoma | In the present study, we show that galectin-3 silencing in cultured human osteos... | BeFree,CTD_human,LHGDN | 25339127 | Detail |
0.136 | osteosarcoma | Our findings suggest a cooperative relationship between miR-410 and VEGF in OS c... | BeFree,CTD_human,LHGDN | 25385479 | Detail |
0.136 | osteosarcoma | Single nucleotide polymorphisms in VEGF gene are associated with an increased ri... | BeFree,CTD_human,LHGDN | 25550863 | Detail |
0.136 | osteosarcoma | Effect of polymorphisms of vascular endothelial growth factor on prognosis in os... | BeFree,CTD_human,LHGDN | 25966208 | Detail |
<0.001 | osteosclerosis | NA | BeFree | Detail | |
0.080 | Otitis Media with Effusion | NA | BeFree,RGD | Detail | |
0.029 | ovarian carcinoma | MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth fa... | BeFree | 25176450 | Detail |
0.029 | ovarian carcinoma | These results suggested that VEGF could impact ovarian cancer's malignant progre... | BeFree | 25192722 | Detail |
0.029 | ovarian carcinoma | The median pretreatment serum VEGF and survivin levels in patients with serous o... | BeFree | 25577253 | Detail |
0.029 | ovarian carcinoma | Our data reveal a new potential pathway in which VEGF promotes the invasion of o... | BeFree | 25597268 | Detail |
0.029 | ovarian carcinoma | IKKβ Regulates VEGF Expression and Is a Potential Therapeutic Target for Ovarian... | BeFree | 25637316 | Detail |
0.029 | ovarian carcinoma | To assess the angiogenic properties of fibulin-4, vascular endothelial growth fa... | BeFree | 25885889 | Detail |
0.003 | Ovarian Cysts | NA | LHGDN | Detail | |
0.001 | Ovarian Diseases | NA | BeFree | Detail | |
0.025 | Pancreatic Neoplasm | The pancreatic tumors of the mice injected with nanoparticles loaded with EPAS1 ... | BeFree,LHGDN | 25672594 | Detail |
0.003 | pancreatitis | NA | LHGDN | Detail | |
<0.001 | papilloma | NA | BeFree | Detail | |
<0.001 | paraganglioma | NA | BeFree | Detail | |
<0.001 | Parathyroid Neoplasms | NA | BeFree | Detail | |
<0.001 | bullous pemphigoid | NA | BeFree | Detail | |
0.003 | Peptic Ulcer | NA | BeFree,GAD | Detail | |
<0.001 | Chronic periaortitis | NA | BeFree | Detail | |
<0.001 | pericardial effusion | NA | BeFree | Detail | |
0.003 | familial Mediterranean fever | NA | BeFree,GAD | Detail | |
0.008 | Periodontal Diseases | NA | BeFree,LHGDN | Detail | |
0.001 | periodontitis | NA | BeFree | Detail | |
<0.001 | Peripheral neuropathy | NA | BeFree | Detail | |
0.002 | Peritoneal Diseases | NA | GAD | Detail | |
0.002 | pheochromocytoma | NA | BeFree | Detail | |
0.003 | pituitary adenoma | The expression profile of Dopamine D2 receptor, MGMT and VEGF in different histo... | BeFree | 25027022 | Detail |
0.002 | Pituitary Diseases | NA | BeFree | Detail | |
0.014 | Pituitary Neoplasms | NA | BeFree,LHGDN | Detail | |
<0.001 | placental insufficiency | NA | BeFree | Detail | |
<0.001 | Pleural Diseases | NA | BeFree | Detail | |
0.008 | Pleural effusion disorder | In malignant pleural effusion caused by cancers of different origin, the vascula... | BeFree,LHGDN | 25425729 | Detail |
0.008 | Pleural effusion disorder | VEGF and EGFR play important roles in the formation of pleural effusion. | BeFree,LHGDN | 25635424 | Detail |
0.003 | pneumonia | NA | BeFree,LHGDN | Detail | |
0.011 | polycystic ovary syndrome | Our findings suggest that the VEGF +405G/C polymorphism may constitute an inheri... | BeFree,GAD,LHGDN | 25106940 | Detail |
0.003 | polycythemia | NA | BeFree,LHGDN | Detail | |
<0.001 | polycythemia vera | NA | BeFree | Detail | |
<0.001 | Adenomatous Polyposis Coli | NA | BeFree | Detail | |
<0.001 | polyps | NA | BeFree | Detail | |
0.022 | pre-eclampsia | NA | GAD,LHGDN | Detail | |
0.123 | Precancerous Conditions | NA | BeFree,CTD_human,GAD | Detail | |
0.002 | Pregnancy Complications, Hematologic | NA | GAD | Detail | |
0.080 | Pregnancy in Diabetics | NA | RGD | Detail | |
0.006 | ectopic pregnancy | Association study of vascular endothelial growth factor gene polymorphisms with ... | BeFree,LHGDN | 25551960 | Detail |
<0.001 | prolactinoma | NA | BeFree | Detail | |
0.169 | Prostatic Neoplasms | NA | BeFree,CTD_human,LHGDN | Detail | |
<0.001 | prostatitis | NA | BeFree | Detail | |
0.120 | proteinuria | NA | CTD_human | Detail | |
<0.001 | Pruritus | NA | BeFree | Detail | |
0.003 | pseudoxanthoma elasticum | Identification of modifier genes, such as vascular endothelial growth factor A, ... | BeFree,GAD | 25264593 | Detail |
0.151 | psoriasis | Psoriasis (Ps) is an autoimmune disease characterized by keratinocyte hyperproli... | BeFree,CTD_human,GAD,LHGDN | 24587411 | Detail |
0.151 | psoriasis | Therefore, we proposed that targeting VEGF/VEGFRs could lead to new treatments f... | BeFree,CTD_human,GAD,LHGDN | 25227750 | Detail |
0.151 | psoriasis | A TACE inhibitor abrogated EGFR ligand-dependent keratinocyte proliferation and ... | BeFree,CTD_human,GAD,LHGDN | 25384035 | Detail |
0.008 | pterygium | NA | BeFree,GAD | Detail | |
0.083 | pulmonary edema | NA | BeFree,GAD,RGD | Detail | |
0.003 | pulmonary emphysema | NA | BeFree | Detail | |
0.003 | pulmonary fibrosis | Overexpression of angiogenic factors (activation of VEGF through HIF-1A) may pre... | BeFree,GAD | 26022899 | Detail |
<0.001 | pulpitis | NA | BeFree | Detail | |
0.005 | Henoch-Schoenlein purpura | NA | BeFree,GAD | Detail | |
0.003 | Rectal Neoplasms | NA | LHGDN | Detail | |
<0.001 | kidney failure | NA | BeFree | Detail | |
0.005 | Respiratory Distress Syndrome, Newborn | NA | BeFree,GAD | Detail | |
0.009 | Respiratory Distress Syndrome, Adult | NA | BeFree,GAD | Detail | |
<0.001 | retinal degeneration | NA | BeFree | Detail | |
0.002 | retinal detachment | NA | BeFree | Detail | |
0.083 | Retinal Neovascularization | NA | LHGDN,RGD | Detail | |
0.203 | retinal vein occlusion | NA | CTD_human,LHGDN,RGD | Detail | |
0.002 | retinoblastoma | Transfection of both genes had greater inhibitory effects on RB development and ... | BeFree | 25218456 | Detail |
0.021 | retinopathy of prematurity | Despite evidence that hypoxia inducible factor (HIF)-1α -VEGF axis is associated... | BeFree,GAD | 24533641 | Detail |
0.021 | retinopathy of prematurity | Our evidence also suggests that the VEGF pathway and downstream NFKB signaling m... | BeFree,GAD | 24874013 | Detail |
0.021 | retinopathy of prematurity | Vascular endothelial growth factor (VEGF) is a key regulator of angiogenesis and... | BeFree,GAD | 25605522 | Detail |
<0.001 | Retroviridae Infections | NA | BeFree | Detail | |
0.124 | rhabdomyosarcoma | NA | BeFree,CTD_human,LHGDN | Detail | |
<0.001 | Rheumatism | NA | BeFree | Detail | |
<0.001 | rhinitis | NA | BeFree | Detail | |
0.014 | sarcoidosis | These findings were in line with previous data on the role of HIF-1A/VEGF/ING-4 ... | BeFree,GAD,LHGDN | 26022899 | Detail |
<0.001 | Sarcoidosis, Pulmonary | NA | BeFree | Detail | |
0.005 | Kaposi sarcoma | Vascular endothelial growth factor A polymorphism and risk of Kaposi's sarcoma h... | BeFree,GAD | 25124076 | Detail |
0.005 | Kaposi sarcoma | Repression of Bcr correlated with the activation of a protein previously shown t... | BeFree,GAD | 25631082 | Detail |
<0.001 | schizophrenia | Association study of VEGFA polymorphisms with schizophrenia in Han Chinese popul... | BeFree | 25641131 | Detail |
<0.001 | scimitar syndrome | NA | BeFree | Detail | |
0.002 | systemic scleroderma | After sorting, we showed: i. an increased production of vascular endothelial gro... | BeFree | 25248297 | Detail |
<0.001 | Septicemia | NA | BeFree | Detail | |
0.003 | Septic Shock | NA | LHGDN | Detail | |
0.006 | Dermatologic disorders | NA | BeFree,GAD | Detail | |
<0.001 | Skin Manifestations | NA | BeFree | Detail | |
<0.001 | Skin Neoplasms | NA | BeFree | Detail | |
<0.001 | Sleep Apnea Syndromes | NA | BeFree | Detail | |
0.003 | Splenomegaly | NA | LHGDN | Detail | |
0.003 | ankylosing spondylitis | NA | BeFree,GAD | Detail | |
0.120 | status epilepticus | NA | CTD_human | Detail | |
0.073 | Stomach Neoplasms | NA | BeFree,GAD,LHGDN | Detail | |
0.127 | gastric ulcer | NA | BeFree,CTD_human,LHGDN | Detail | |
0.090 | Cerebrovascular accident | In conclusion, IL-8 stimulates VEGF production in hBM-MSCs in part via the PI3K/... | BeFree,GAD,RGD | 24797366 | Detail |
0.090 | Cerebrovascular accident | Transplantation of BMSCs stably expressing mutant HIF1α significantly improved m... | BeFree,GAD,RGD | 25270619 | Detail |
0.090 | Cerebrovascular accident | Our findings have implications for the use of cancer therapies that target VEGF ... | BeFree,GAD,RGD | 26081809 | Detail |
<0.001 | Sturge-Weber syndrome | NA | BeFree | Detail | |
0.006 | sudden infant death syndrome | NA | BeFree,LHGDN | Detail | |
0.003 | progressive supranuclear palsy | NA | BeFree,GAD | Detail | |
<0.001 | synovial sarcoma | NA | BeFree | Detail | |
0.004 | synovitis | NA | BeFree,LHGDN | Detail | |
0.003 | hereditary hemorrhagic telangiectasia | NA | BeFree,LHGDN | Detail | |
0.006 | Giant Cell Arteritis | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Testicular Neoplasms | NA | BeFree | Detail | |
0.003 | tetralogy of Fallot | NA | BeFree,GAD | Detail | |
0.003 | thromboangiitis obliterans | NA | BeFree,LHGDN | Detail | |
0.004 | Thrombocythemia, Essential | NA | BeFree,LHGDN | Detail | |
0.002 | thrombosis | NA | GAD | Detail | |
<0.001 | thymoma | NA | BeFree | Detail | |
0.018 | Thyroid Neoplasm | The rates of positive immunostaining for COX-2, MMP-9 and VEGF in PTC tumours we... | BeFree,GAD,LHGDN | 24670538 | Detail |
<0.001 | Thyroid Nodule | NA | BeFree | Detail | |
<0.001 | thyroiditis | NA | BeFree | Detail | |
<0.001 | Truncus Arteriosus, Persistent | Indeed, we demonstrate in two multiplex consanguineous families that we are able... | BeFree | 25713110 | Detail |
<0.001 | Tuberculoma | NA | BeFree | Detail | |
<0.001 | Tuberculosis, Meningeal | NA | BeFree | Detail | |
<0.001 | tuberous sclerosis | NA | BeFree | Detail | |
0.001 | Unipolar Depression | Vascular endothelial growth factor A gene expression level is higher in patients... | BeFree | 24718046 | Detail |
<0.001 | uremia | To investigate microvessel density (MVD), vascular endothelial growth factor (VE... | BeFree | 25000894 | Detail |
0.003 | urinary tract infection | NA | BeFree,LHGDN | Detail | |
<0.001 | urticaria | Calcitonin gene-related peptide and vascular endothelial growth factor are expre... | BeFree | 24902612 | Detail |
0.001 | Uterine Fibroids | NA | BeFree | Detail | |
0.002 | Uterine Neoplasms | NA | GAD | Detail | |
<0.001 | Varicose Ulcer | NA | BeFree | Detail | |
<0.001 | Varicosity | NA | BeFree | Detail | |
0.005 | Vascular Diseases | NA | BeFree,GAD | Detail | |
0.002 | Ventricular Outflow Obstruction | NA | GAD | Detail | |
0.003 | Vesico-Ureteral Reflux | NA | BeFree,LHGDN | Detail | |
0.003 | Viremia | NA | LHGDN | Detail | |
0.001 | Virus Diseases | NA | BeFree | Detail | |
0.002 | Low Vision | NA | GAD | Detail | |
<0.001 | von Willebrand Disease | NA | BeFree | Detail | |
0.003 | Yersinia infections | NA | LHGDN | Detail | |
<0.001 | AIDS-Associated Nephropathy | NA | BeFree | Detail | |
<0.001 | Fibromatosis, Aggressive | NA | BeFree | Detail | |
<0.001 | Hallopeau-Siemens Disease | Increased TGFβ signaling and VEGF expression were observed in Col7 KD xenografts... | BeFree | 26476432 | Detail |
0.002 | Helicobacter Infections | NA | GAD | Detail | |
<0.001 | Ichthyosis, X-Linked | NA | BeFree | Detail | |
0.006 | B-Cell Lymphomas | NA | BeFree,LHGDN | Detail | |
<0.001 | diffuse large B-cell lymphoma | NA | BeFree | Detail | |
<0.001 | Lymphoma, Large-Cell, Follicular | NA | BeFree | Detail | |
<0.001 | T-Cell Lymphoma | Consequently, genetic or pharmacologic inhibition of integrin αvβ3 decreased VEG... | BeFree | 25488971 | Detail |
0.003 | Lymphoma, T-Cell, Cutaneous | NA | BeFree,LHGDN | Detail | |
0.002 | Pleural Effusion, Malignant | Targeting VEGF and interleukin-6 for controlling malignant effusion of primary e... | BeFree | 25304617 | Detail |
0.002 | Pleural Effusion, Malignant | The detection of LUNX mRNA and vascular endothelial growth factor mRNA in pleura... | BeFree | 25425729 | Detail |
0.002 | Pleural Effusion, Malignant | VEGF differed significantly in benign and malignant pleural effusions, which con... | BeFree | 25635424 | Detail |
0.004 | ovarian hyperstimulation syndrome | Polymorphisms of VEGF and VEGF receptors are associated with the occurrence of o... | BeFree | 24851136 | Detail |
<0.001 | motor neuron disease | NA | BeFree | Detail | |
0.004 | Peripheral Vascular Diseases | NA | BeFree | Detail | |
0.124 | corneal neovascularization | Subconjunctival bevacizumab helps to regress CNV due to a decrease in corneal VE... | BeFree,CTD_human | 25090164 | Detail |
0.002 | severe combined immunodeficiency | NA | BeFree | Detail | |
<0.001 | Central Nervous System Neoplasms | NA | BeFree | Detail | |
0.002 | Neoplasms, Second Primary | NA | GAD | Detail | |
<0.001 | Intracranial Tuberculoma | NA | BeFree | Detail | |
0.006 | POEMS syndrome | NA | BeFree,LHGDN | Detail | |
<0.001 | angiodysplasia | NA | BeFree | Detail | |
0.003 | Polycystic Kidney, Autosomal Dominant | NA | BeFree,GAD | Detail | |
<0.001 | essential hypertension | NA | BeFree | Detail | |
0.120 | Liver failure | NA | CTD_human | Detail | |
0.002 | Synovial Cyst | NA | BeFree | Detail | |
0.003 | polymyositis | NA | LHGDN | Detail | |
0.001 | acute leukemia | NA | BeFree | Detail | |
<0.001 | Chronic cholecystitis | High expression of VEGF-A was observed in 81% (183/224) of tumors and 5.1% (2/39... | BeFree | 24185122 | Detail |
<0.001 | Idiopathic Membranous Glomerulonephritis | NA | BeFree | Detail | |
0.001 | benign neoplasm | NA | BeFree | Detail | |
0.003 | Pancreatitis, Chronic | NA | BeFree,GAD | Detail | |
<0.001 | Bicuspid aortic valve | NA | BeFree | Detail | |
<0.001 | Left Ventricular Hypertrophy | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of lung | NA | BeFree | Detail | |
<0.001 | Deep Vein Thrombosis | NA | BeFree | Detail | |
0.005 | Small cell carcinoma of lung | NA | BeFree,LHGDN | Detail | |
0.003 | Migraine Disorders | NA | BeFree,GAD | Detail | |
<0.001 | Adenocarcinoma of rectum | NA | BeFree | Detail | |
<0.001 | Sensory neuropathy | NA | BeFree | Detail | |
<0.001 | Thyroid Gland Follicular Adenoma | NA | BeFree | Detail | |
0.015 | Premature Birth | NA | GAD,LHGDN | Detail | |
<0.001 | Oral Cavity Carcinoma | It seems therefore that serum VEGF level may be a reliable biomarker and may be ... | BeFree | 24833243 | Detail |
0.130 | Myocardial Ischemia | NA | BeFree,CTD_human,GAD | Detail | |
0.003 | Cutaneous Melanoma | NA | BeFree,GAD | Detail | |
0.001 | Coronary Occlusion | Cardiomyocyte-specific overexpression of the α1A-adrenergic receptors resulted i... | BeFree | 26338300 | Detail |
<0.001 | Deep thrombophlebitis | NA | BeFree | Detail | |
<0.001 | Ulcer of esophagus | NA | BeFree | Detail | |
0.003 | Adenocarcinoma of lung (disorder) | NA | BeFree | Detail | |
0.004 | esophageal carcinoma | Role of +405C>G and +936C>T polymorphisms of the vascular endothelial growth fac... | BeFree | 25640399 | Detail |
0.001 | congenital heart disease | NA | BeFree | Detail | |
<0.001 | polyneuropathy | NA | BeFree | Detail | |
0.001 | Idiopathic pulmonary hypertension | Administration of BMP9 reversed established PAH in these mice, as well as in two... | BeFree | 26076038 | Detail |
<0.001 | Malignant neoplasm of tongue | NA | BeFree | Detail | |
0.009 | Malignant neoplasm of mouth | Serum VEGF levels were significantly higher in oral cancer patients (p<0.0001) a... | BeFree,GAD | 24833243 | Detail |
0.009 | Malignant neoplasm of mouth | VEGFA isoforms play a vital role in oral cancer progression. | BeFree,GAD | 25804797 | Detail |
<0.001 | Malignant neoplasm of nasopharynx | NA | BeFree | Detail | |
0.002 | Malignant neoplasm of gallbladder | Our results indicate that VEGF-A is highly expressed in GBC and correlates with ... | BeFree | 24185122 | Detail |
0.004 | Secondary malignant neoplasm of lung | NA | BeFree | Detail | |
0.002 | Secondary malignant neoplasm of bone | Bone metastases (BMs) are associated with poor outcome in metastatic clear-cell ... | BeFree | 26528707 | Detail |
<0.001 | Hemangioma of retina | NA | BeFree | Detail | |
<0.001 | Stage 0 Breast Carcinoma | NA | BeFree | Detail | |
<0.001 | Traction detachment of retina | NA | BeFree | Detail | |
<0.001 | Exudative retinopathy | NA | BeFree | Detail | |
<0.001 | central retinal vein occlusion | NA | BeFree | Detail | |
0.001 | rubeosis iridis | NA | BeFree | Detail | |
0.001 | Corneal pannus | NA | BeFree | Detail | |
0.003 | acute myocardial infarction | NA | BeFree | Detail | |
<0.001 | Acute bacterial endocarditis | NA | BeFree | Detail | |
<0.001 | allergic asthma | NA | BeFree | Detail | |
<0.001 | Idiopathic urticaria | Increased expression of CGRP and VEGF in lesional, but not uninvolved, skin indi... | BeFree | 24902612 | Detail |
0.002 | Vascular anomaly | NA | BeFree | Detail | |
0.001 | retinal ischemia | NA | BeFree | Detail | |
0.003 | Colitis, Ischemic | NA | BeFree,LHGDN | Detail | |
<0.001 | Neurofibromatoses | NA | BeFree | Detail | |
0.003 | HELLP syndrome | NA | BeFree,GAD | Detail | |
<0.001 | Right Ventricular Hypertrophy | Recently, proangiogenic factors hypoxia-inducible factor-1 alpha (HIF-1α) and va... | BeFree | 25301555 | Detail |
0.080 | Dermatitis, Allergic Contact | NA | RGD | Detail | |
<0.001 | Aortic Aneurysm, Abdominal | In this study, the functional variants in genes involved in the hypoxia signalin... | BeFree | 24657063 | Detail |
<0.001 | Aortic Aneurysm, Thoracic | The haplotype analysis suggested that the TAA (VEGF -460/-1154/-2578) and CAA ha... | BeFree | 25551960 | Detail |
<0.001 | Agenesis of corpus callosum | We retrieved 27 cases of 1-4-cm-sized adenoid cystic carcinomas (ACCs) arising f... | BeFree | 24456477 | Detail |
0.001 | Glomerulosclerosis (disorder) | NA | BeFree | Detail | |
0.030 | Tumor Progression | Regarding the significant role of vascular endothelial growth factor (VEGF) in a... | BeFree | 25039617 | Detail |
0.030 | Tumor Progression | IR also triggers cellular secretion of vascular endothelial growth factor, trans... | BeFree | 25052686 | Detail |
0.030 | Tumor Progression | No significant risk for developing tumor progression was associated with Ki-67, ... | BeFree | 25109698 | Detail |
0.030 | Tumor Progression | Recent evidence indicates that LKB1 alterations contribute to cancer progression... | BeFree | 25179843 | Detail |
0.030 | Tumor Progression | Vascular endothelial growth factor-C (VEGF-C) plays an important role during can... | BeFree | 25212831 | Detail |
0.030 | Tumor Progression | VEGF-A is the most established angiogenic factor involved in the angiogenic-regu... | BeFree | 25738362 | Detail |
0.030 | Tumor Progression | Our results support that osteopontin regulates ICAM-1 and VEGFA expression mainl... | BeFree | 25972323 | Detail |
<0.001 | urinary tract obstruction | Expression of VEGF in neonatal urinary obstruction: does expression of VEGF pred... | BeFree | 25951999 | Detail |
<0.001 | Anaplastic carcinoma | NA | BeFree | Detail | |
<0.001 | Carcinomatosis | NA | BeFree | Detail | |
<0.001 | Germ cell tumor | Given the preclinical evidence implicating vascular endothelial growth factor (V... | BeFree | 25085632 | Detail |
<0.001 | Sarcoma, Spindle Cell | NA | BeFree | Detail | |
<0.001 | Diabetic Foot | NA | BeFree | Detail | |
<0.001 | Ki-1+ Anaplastic Large Cell Lymphoma | NA | BeFree | Detail | |
0.080 | Tympanic Membrane Perforation | NA | RGD | Detail | |
<0.001 | hepatoblastoma | NA | BeFree | Detail | |
<0.001 | alveolar rhabdomyosarcoma | NA | BeFree | Detail | |
<0.001 | Rhabdomyosarcoma, Embryonal | NA | BeFree | Detail | |
<0.001 | Neuroectodermal Tumor, Primitive | NA | BeFree | Detail | |
<0.001 | Adenomatous Polyps | NA | BeFree | Detail | |
0.003 | Adenocarcinoma, Clear Cell | NA | BeFree,LHGDN | Detail | |
<0.001 | Follicular thyroid carcinoma | NA | BeFree | Detail | |
<0.001 | Carcinoma, Lobular | NA | BeFree | Detail | |
0.007 | cholangiocarcinoma | The molecular and cellular functions predicted for these CCA specific genes acco... | BeFree,LHGDN | 24935374 | Detail |
<0.001 | Cystadenocarcinoma, Serous | NA | BeFree | Detail | |
0.001 | Cervical Intraepithelial Neoplasia | NA | BeFree | Detail | |
0.003 | Squamous Cell Neoplasms | NA | LHGDN | Detail | |
0.120 | gliosarcoma | NA | CTD_human | Detail | |
<0.001 | Nerve Sheath Tumors | NA | BeFree | Detail | |
<0.001 | Epithelioid hemangioendothelioma | NA | BeFree | Detail | |
0.002 | Strawberry nevus of skin | Collectively, our data provide evidence that propranolol may regress infantile h... | BeFree | 25872592 | Detail |
0.004 | hemangioblastoma | The VHL-HIF-1 regulated genes VEGF and CAIX are expressed in hemangioblastomas b... | BeFree | 25310734 | Detail |
0.003 | Melanoma, Amelanotic | NA | LHGDN | Detail | |
0.001 | Neuroendocrine Tumors | Neuroendocrine cancer cell lines are used to investigate therapeutic targets in ... | BeFree | 26087898 | Detail |
<0.001 | pediatric acute myeloblastic leukemia | NA | BeFree | Detail | |
0.002 | uveal melanoma | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of salivary gland | NA | BeFree | Detail | |
0.004 | Lip and oral cavity carcinoma | It seems therefore that serum VEGF level may be a reliable biomarker and may be ... | BeFree | 24833243 | Detail |
0.004 | Lip and oral cavity carcinoma | VEGFA isoforms play a vital role in oral cancer progression. | BeFree | 25804797 | Detail |
0.002 | Metastatic malignant neoplasm to brain | NA | BeFree | Detail | |
0.002 | Malignant ascites | NA | BeFree | Detail | |
<0.001 | Niemann-Pick disease, type C | Overall, these results reveal a pathogenic mechanism in NP-C neurons where defec... | BeFree | 25417698 | Detail |
<0.001 | Kasabach-Merritt syndrome | NA | BeFree | Detail | |
<0.001 | Comedone | NA | BeFree | Detail | |
<0.001 | Pseudolymphoma | NA | BeFree | Detail | |
<0.001 | Hydrosalpinx (disease) | NA | BeFree | Detail | |
<0.001 | Malaise | NA | BeFree | Detail | |
<0.001 | Fibrillation | NA | BeFree | Detail | |
<0.001 | Intermenstrual heavy bleeding | NA | BeFree | Detail | |
<0.001 | Mental condensation | NA | BeFree | Detail | |
<0.001 | Sensory Discomfort | NA | BeFree | Detail | |
<0.001 | Rest pain | NA | BeFree | Detail | |
<0.001 | Ataxic | NA | BeFree | Detail | |
0.003 | Port-Wine Stain | NA | LHGDN | Detail | |
0.002 | gallbladder carcinoma | Immunohistochemical expression of vascular endothelial growth factor A in advanc... | BeFree | 24185122 | Detail |
0.080 | congenital diaphragmatic hernia | NA | BeFree,RGD | Detail | |
0.019 | pancreatic carcinoma | Our results demonstrated that DAPK1 gene over-expression can suppress the prolif... | BeFree | 25550789 | Detail |
0.019 | pancreatic carcinoma | VEGF-A is the most specific and prominent angiogenic factor among all family mem... | BeFree | 26710495 | Detail |
<0.001 | Pick Disease of the Brain | NA | BeFree | Detail | |
<0.001 | Carcinoma of male breast | NA | BeFree | Detail | |
0.005 | Gastrointestinal Stromal Tumors | Clinical significance of vascular endothelial growth factor and vascular endothe... | BeFree,LHGDN | 23551429 | Detail |
<0.001 | Acute mountain sickness | NA | BeFree | Detail | |
<0.001 | Cancer of Nasopharynx | NA | BeFree | Detail | |
<0.001 | Hereditary pancreatitis | NA | BeFree | Detail | |
<0.001 | Anaplastic thyroid carcinoma | NA | BeFree | Detail | |
0.002 | Medullary carcinoma of thyroid | NA | BeFree | Detail | |
0.002 | Papillary thyroid carcinoma | Immunohistochemical levels of cyclo-oxygenase-2, matrix metalloproteinase-9 and ... | BeFree | 24670538 | Detail |
<0.001 | Edema of lower extremity | NA | BeFree | Detail | |
<0.001 | Fibrosis, Liver | NA | BeFree | Detail | |
<0.001 | Interstitial fibrosis | NA | BeFree | Detail | |
<0.001 | coronary stenosis | NA | BeFree | Detail | |
0.121 | Erectile dysfunction | NA | BeFree,CTD_human | Detail | |
0.080 | Acute Lung Injury | NA | RGD | Detail | |
<0.001 | Neoplasm, Residual | NA | BeFree | Detail | |
0.002 | Oxidative Stress | NA | GAD | Detail | |
0.003 | Disease Progression | NA | LHGDN | Detail | |
<0.001 | Proliferative vitreoretinopathy | NA | BeFree | Detail | |
<0.001 | Hantavirus Infections | NA | BeFree | Detail | |
0.003 | viral encephalitis | NA | LHGDN | Detail | |
0.003 | Sepsis | NA | BeFree,LHGDN | Detail | |
<0.001 | Carcinoma, Lewis Lung | Captopril and losartan also suppressed vascular endothelial growth factor-A expr... | BeFree | 25511041 | Detail |
0.002 | Cardiovascular Abnormalities | NA | GAD | Detail | |
<0.001 | Collagen-vascular disease | NA | BeFree | Detail | |
<0.001 | Myxoma of the Endocardium | NA | BeFree | Detail | |
<0.001 | Rotator cuff syndrome | NA | BeFree | Detail | |
<0.001 | Childhood asthma | NA | BeFree | Detail | |
<0.001 | Acute respiratory failure | NA | BeFree | Detail | |
0.002 | Chronic myocardial ischemia | NA | BeFree | Detail | |
<0.001 | Chronic heart failure | NA | BeFree | Detail | |
<0.001 | Secondary pulmonary hypertension | NA | BeFree | Detail | |
<0.001 | Ulcer of artery | NA | BeFree | Detail | |
<0.001 | carotid artery occlusion | NA | BeFree | Detail | |
<0.001 | Congenital hypoplasia of pulmonary artery | NA | BeFree | Detail | |
<0.001 | Abnormal yolk sac | NA | BeFree | Detail | |
<0.001 | Erosive esophagitis | NA | BeFree | Detail | |
<0.001 | Angiodysplasia of colon | NA | BeFree | Detail | |
<0.001 | Senile cardiac amyloidosis | NA | BeFree | Detail | |
<0.001 | Isovaleryl-CoA dehydrogenase deficiency | i) Serum VEGF levels were higher in patients with progressive disease than those... | BeFree | 25862879 | Detail |
0.002 | Renal glomerular disease | NA | BeFree | Detail | |
<0.001 | Renal vascular disorder | NA | BeFree | Detail | |
0.001 | Endometrioma | NA | BeFree | Detail | |
<0.001 | Spastic syndrome | Mechanical stimuli, like mechanical stretch in respiratory and circulatory syste... | BeFree | 25951999 | Detail |
0.128 | macular retinal edema | Conbercept (KH902), a novel recombinant, soluble vascular endothelial growth fac... | BeFree,CTD_human,GAD,LHGDN | 25737631 | Detail |
0.128 | macular retinal edema | The aqueous humor levels of IL-1β, IL-6, IL-8, MCP-1, IP-10, and VEGF were close... | BeFree,CTD_human,GAD,LHGDN | 25923230 | Detail |
0.006 | Exudative age-related macular degeneration | Ocular anti-VEGF therapy is highly effective for treating a subset of patients w... | BeFree | 25457617 | Detail |
0.006 | Exudative age-related macular degeneration | Differential expression of vascular endothelial growth factor-a isoforms in neov... | BeFree | 25494018 | Detail |
0.006 | Exudative age-related macular degeneration | Pharmacogenomics of response to anti-VEGF therapy in exudative age-related macul... | BeFree | 25635578 | Detail |
0.006 | Exudative age-related macular degeneration | Here, we engineered a Two-in-One VEGF/angiopoietin 2 antibody with dual action F... | BeFree | 26088137 | Detail |
<0.001 | Severe myopia | NA | BeFree | Detail | |
<0.001 | Central blindness | Based on our data comparing human IL-18 to current anti-VEGF-based therapy, clin... | BeFree | 26284546 | Detail |
<0.001 | Blindness of one eye (disorder) | Ocular anti-VEGF therapy is highly effective for treating a subset of patients w... | BeFree | 25457617 | Detail |
<0.001 | Chronic otitis media | NA | BeFree | Detail | |
<0.001 | Impaired glucose tolerance | NA | BeFree | Detail | |
<0.001 | Diabetic Polyneuropathies | NA | BeFree | Detail | |
<0.001 | Chronic mountain sickness | Vascular endothelial growth factor-A is associated with chronic mountain sicknes... | BeFree | 24971768 | Detail |
<0.001 | Primary bacterial peritonitis | NA | BeFree | Detail | |
<0.001 | AIDS with Kaposi's sarcoma | NA | BeFree | Detail | |
0.002 | Hemifacial Spasm | NA | GAD | Detail | |
<0.001 | Stage II Colon Cancer | NA | BeFree | Detail | |
<0.001 | Stage III Colon Cancer | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of colon stage IV | NA | BeFree | Detail | |
0.004 | Carcinoma breast stage IV | Association of VEGF-A splice variant mRNA expression with outcome in bevacizumab... | BeFree | 24703319 | Detail |
<0.001 | Non-small cell lung cancer stage I | Of the 102 stage I NSCLC specimens analyzed, high RBP2 protein expression is clo... | BeFree | 25162518 | Detail |
<0.001 | recurrent childhood acute lymphoblastic leukemia | NA | BeFree | Detail | |
0.001 | inflammatory breast carcinoma | NA | BeFree | Detail | |
0.003 | Metastatic Renal Cell Cancer | MEDLINE/PubMed and the Cochrane Library were searched for randomised phase III t... | BeFree | 25410406 | Detail |
0.003 | Metastatic Renal Cell Cancer | The aim of this prospective, noninterventional, observational study was to asses... | BeFree | 25925846 | Detail |
<0.001 | Stage IV Ovarian Carcinoma | NA | BeFree | Detail | |
<0.001 | Disseminated neuroblastoma | NA | BeFree | Detail | |
<0.001 | gastric adenocarcinoma | NA | BeFree | Detail | |
<0.001 | Malignant Childhood Neoplasm | NA | BeFree | Detail | |
0.002 | Metastatic melanoma | NA | BeFree | Detail | |
<0.001 | Melanoma recurrent | NA | BeFree | Detail | |
0.006 | Cancer of Head and Neck | NA | BeFree,GAD | Detail | |
0.002 | Liver and Intrahepatic Biliary Tract Carcinoma | Sorafenib (SOR), a vascular endothelial growth factor receptor (VEGFR) inhibitor... | BeFree | 25176394 | Detail |
0.003 | Squamous cell carcinoma of esophagus | Genetic variants of EGF and VEGF predict prognosis of patients with advanced eso... | BeFree | 24945674 | Detail |
0.003 | Squamous cell carcinoma of esophagus | RhoC, vascular endothelial growth factor and microvascular density in esophageal... | BeFree | 25624724 | Detail |
0.003 | Adenocarcinoma Of Esophagus | Discovery and validation of vascular endothelial growth factor (VEGF) pathway po... | BeFree | 26014353 | Detail |
<0.001 | Serous cystadenocarcinoma ovary | NA | BeFree | Detail | |
0.002 | Transitional cell carcinoma of bladder | NA | BeFree | Detail | |
<0.001 | bladder squamous cell carcinoma | Given that the tumor-promoting inflammation has been previously established in s... | BeFree | 24448750 | Detail |
<0.001 | Adenoid cystic carcinoma of salivary gland | NA | BeFree | Detail | |
<0.001 | extraosseous Ewings sarcoma-primitive neuroepithelial tumor | NA | BeFree | Detail | |
0.019 | Solid tumour | Dual antiangiogenic inhibition: a phase I dose escalation and expansion trial ta... | BeFree | 25363205 | Detail |
0.019 | Solid tumour | Specific variations of VEGF genes have been demonstrated to be genetic determina... | BeFree | 25560471 | Detail |
0.019 | Solid tumour | The failure of standard treatment for patients diagnosed with glioblastoma (GBM)... | BeFree | 25676691 | Detail |
0.019 | Solid tumour | Patients with refractory solid tumors were enrolled in a modified 3 + 3 Phase I ... | BeFree | 25902899 | Detail |
<0.001 | Acute Undifferentiated Leukemia | NA | BeFree | Detail | |
<0.001 | stage, non-small cell lung cancer | NA | BeFree | Detail | |
<0.001 | stage, ovarian epithelial cancer | NA | BeFree | Detail | |
<0.001 | stage, prostate cancer | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of the hypopharynx | Significance of the expression of integrin β1, VEGF and MVD in hypopharyngeal sq... | BeFree | 25158264 | Detail |
<0.001 | laryngeal squamous cell carcinoma | NA | BeFree | Detail | |
<0.001 | secondary acute myeloid leukemia | NA | BeFree | Detail | |
<0.001 | uterine carcinosarcoma | NA | BeFree | Detail | |
<0.001 | diffuse astrocytoma | NA | BeFree | Detail | |
0.003 | Adenocarcinoma of pancreas | NA | BeFree | Detail | |
<0.001 | interstitial cystitis | NA | BeFree | Detail | |
<0.001 | leukostasis | NA | BeFree | Detail | |
0.002 | Vascular Neoplasms | NA | BeFree | Detail | |
0.010 | cervix carcinoma | Effects of VEGF suppression by small hairpin RNA interference combined with radi... | BeFree | 25061734 | Detail |
0.010 | cervix carcinoma | Molecular regulation of cervical cancer growth and invasion by VEGFa. | BeFree | 25135429 | Detail |
0.010 | cervix carcinoma | To investigate the effect of recombinant human p53 adenovirus injection combined... | BeFree | 25855930 | Detail |
<0.001 | Anastomosis | NA | BeFree | Detail | |
0.002 | Restenosis | NA | BeFree | Detail | |
0.001 | Healing ulcer | NA | BeFree | Detail | |
<0.001 | Chronic ulcer | NA | BeFree | Detail | |
<0.001 | Superficial ulcer | NA | BeFree | Detail | |
<0.001 | Sarcoid type granuloma | NA | BeFree | Detail | |
0.002 | Tumor necrosis | Importantly, the therapeutic mechanism of antitumor effect mediated by RdB/FP3 i... | BeFree | 25944623 | Detail |
0.002 | Atrophic | NA | GAD | Detail | |
<0.001 | High-Grade Squamous Intraepithelial Lesions | NA | BeFree | Detail | |
<0.001 | pleomorphic carcinoma | Anti-VEGF therapy may be a candidate for PPC, while cisplatin also remains a via... | BeFree | 26031756 | Detail |
<0.001 | Papillary transitional cell carcinoma | NA | BeFree | Detail | |
<0.001 | Carcinoid tumor no ICD-O subtype | NA | BeFree | Detail | |
<0.001 | Comedocarcinoma, noninfiltrating | NA | BeFree | Detail | |
<0.001 | Sclerosing stromal tumor | NA | BeFree | Detail | |
0.001 | Arteriovenous hemangioma | NA | BeFree | Detail | |
<0.001 | Epithelioid hemangioendothelioma, malignant | NA | BeFree | Detail | |
0.002 | anaplastic astrocytoma | NA | BeFree | Detail | |
<0.001 | pilocytic astrocytoma | NA | BeFree | Detail | |
<0.001 | anaplastic oligodendroglioma | Within the 1p/19q-codeleted AO, the contrast enhancement was associated with lar... | BeFree | 24353325 | Detail |
<0.001 | angiomatous meningioma | NA | BeFree | Detail | |
<0.001 | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of colon | NA | BeFree | Detail | |
0.003 | frontotemporal dementia | NA | BeFree,GAD | Detail | |
<0.001 | Impaired cognition | NA | BeFree | Detail | |
0.001 | Proliferative retinopathy | NA | BeFree | Detail | |
<0.001 | Venous retinal branch occlusion | NA | BeFree | Detail | |
<0.001 | Sorsby's fundus dystrophy | Intravitreal anti-VEGF therapy if initiated timely is effective in SFD patients ... | BeFree | 25766588 | Detail |
<0.001 | Familial exudative vitreoretinopathy | NA | BeFree | Detail | |
<0.001 | Epiretinal Membrane | NA | BeFree | Detail | |
<0.001 | High altitude pulmonary edema | NA | BeFree | Detail | |
<0.001 | Complicated pneumoconiosis | NA | BeFree | Detail | |
<0.001 | Stable angina | NA | BeFree | Detail | |
<0.001 | Anterior myocardial infarction | NA | BeFree | Detail | |
<0.001 | Critical lower limb ischemia | NA | BeFree | Detail | |
<0.001 | Arteriovenous fistula thrombosis | Role of the VEGF 936 gene polymorphism and VEGF-A levels in the late-term arteri... | BeFree | 24748065 | Detail |
<0.001 | endometriosis of uterus | NA | BeFree | Detail | |
0.120 | Complications of Diabetes Mellitus | NA | CTD_human | Detail | |
<0.001 | Malonic aciduria | NA | BeFree | Detail | |
<0.001 | capillary leak syndrome | NA | BeFree | Detail | |
0.002 | Malignant neoplasm of liver | Sorafenib (SOR), a vascular endothelial growth factor receptor (VEGFR) inhibitor... | BeFree | 25176394 | Detail |
<0.001 | intrahepatic cholangiocarcinoma | NA | BeFree | Detail | |
0.002 | malignant mesothelioma | NA | BeFree | Detail | |
<0.001 | Breast Cancer, Familial | NA | BeFree | Detail | |
<0.001 | dysgerminoma of ovary | NA | BeFree | Detail | |
<0.001 | Multiple malignancy | In this study, we reported for the first time that Celastrol could induce HIF-1α... | BeFree | 25383959 | Detail |
0.016 | Malignant neoplasm of pancreas | VEGF-A is the most specific and prominent angiogenic factor among all family mem... | BeFree | 26710495 | Detail |
<0.001 | Disseminated Malignant Neoplasm | NA | BeFree | Detail | |
<0.001 | Secondary malignant neoplasm of pancreas | NA | BeFree | Detail | |
<0.001 | Depressive episode, unspecified | VEGF levels were measured in serum by immunoassay and independent determinants o... | BeFree | 24636631 | Detail |
<0.001 | Cervical intraepithelial neoplasia grade 2 | NA | BeFree | Detail | |
<0.001 | Fetal Hypoxia | NA | BeFree | Detail | |
0.001 | Squamous cell carcinoma of tongue | Sevoflurane attenuate hypoxia-induced VEGF level in tongue squamous cell carcino... | BeFree | 25960229 | Detail |
<0.001 | intracranial meningioma | NA | BeFree | Detail | |
<0.001 | Ischemic cardiomyopathy | NA | BeFree | Detail | |
<0.001 | Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | Although Helicobacter pylori have been known to induce vascular endothelial grow... | BeFree | 25231285 | Detail |
0.001 | Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site | NA | BeFree | Detail | |
0.044 | Malignant neoplasm of prostate | Associations of nm23H1, VEGF-C, and VEGF-3 receptor in human prostate cancer. | BeFree,GAD | 24858271 | Detail |
0.044 | Malignant neoplasm of prostate | Vasoactive intestinal peptide (VIP) exerts similar effects in prostate cancer mo... | BeFree,GAD | 25446255 | Detail |
0.044 | Malignant neoplasm of prostate | Adiponectin inhibits VEGF-A in prostate cancer cells. | BeFree,GAD | 25586350 | Detail |
0.002 | Hematologic Neoplasms | NA | BeFree | Detail | |
0.002 | Congenital diverticulum of pharynx | NA | GAD | Detail | |
<0.001 | Irreversible pulpitis | NA | BeFree | Detail | |
<0.001 | Non-alcoholic Fatty Liver Disease | NA | BeFree | Detail | |
<0.001 | Steroid-sensitive nephrotic syndrome | NA | BeFree | Detail | |
<0.001 | Idiopathic crescentic glomerulonephritis | NA | BeFree | Detail | |
<0.001 | Chronic Kidney Insufficiency | NA | BeFree | Detail | |
<0.001 | Chronic rejection of renal transplant | NA | BeFree | Detail | |
<0.001 | Chronic small plaque psoriasis | NA | BeFree | Detail | |
<0.001 | Idiopathic osteoarthritis | NA | BeFree | Detail | |
0.003 | Osteoarthritis, Knee | Follistatin, angiopoietin-2, and VEGF may have potential as biochemical markers ... | BeFree,GAD | 24966080 | Detail |
<0.001 | Muscle damage | NA | BeFree | Detail | |
<0.001 | Aortic valve calcification | NA | BeFree | Detail | |
<0.001 | Microinvasive carcinoma | NA | BeFree | Detail | |
<0.001 | neuropathy | NA | BeFree | Detail | |
<0.001 | Septal hypertrophy | NA | BeFree | Detail | |
0.002 | Blind Vision | NA | GAD | Detail | |
<0.001 | Nevus elasticus | NA | BeFree | Detail | |
0.010 | endometrial carcinoma | Alterations of angiogenic factors including angiotensin (AngII) or VEGF are obse... | BeFree | 25231075 | Detail |
0.010 | endometrial carcinoma | We assessed the safety and activity of dovitinib, a potent tyrosine-kinase inhib... | BeFree | 25981814 | Detail |
0.007 | Secondary malignant neoplasm of liver | Our experimental results suggest that HCS has some anti-metastasis potential to ... | BeFree | 25496480 | Detail |
0.007 | Secondary malignant neoplasm of liver | This study showed that Lcn2-engineered MSCs (MSC-Lcn2) not only inhibited liver ... | BeFree | 25740061 | Detail |
<0.001 | Malignant neoplasm of appendix | NA | BeFree | Detail | |
0.002 | dementia | NA | GAD | Detail | |
<0.001 | Necrotizing Enterocolitis | Intestinal vascular endothelial growth factor is decreased in necrotizing entero... | BeFree | 25659996 | Detail |
<0.001 | prostatic adenoma | NA | BeFree | Detail | |
0.001 | Sleep Apnea, Obstructive | Vascular endothelial growth factor genotypes and haplotypes contribute to the su... | BeFree | 25541696 | Detail |
0.003 | Recurrent tumor | NA | BeFree | Detail | |
<0.001 | Peritoneal Fibrosis | Therefore, we studied peritoneal expression of CCN2, as well as TGFβ1 and VEGF, ... | BeFree | 25384022 | Detail |
0.003 | Metabolic syndrome X | Interplay between 3'-UTR polymorphisms in the vascular endothelial growth factor... | BeFree,GAD | 25423914 | Detail |
0.006 | Neurodegenerative Disorders | NA | BeFree,LHGDN | Detail | |
0.003 | Hepatitis C, Chronic | NA | BeFree,LHGDN | Detail | |
0.009 | Malignant neoplasm of esophagus | Role of +405C>G and +936C>T polymorphisms of the vascular endothelial growth fac... | BeFree,GAD | 25640399 | Detail |
<0.001 | Subacromial bursitis | NA | BeFree | Detail | |
0.006 | Thyroid carcinoma | Transient Receptor Potential Canonical 1 (TRPC1) Channels as Regulators of Sphin... | BeFree | 25971967 | Detail |
<0.001 | Squamous cell carcinoma of skin | NA | BeFree | Detail | |
0.005 | Malignant glioma | Correlation between ¹⁸F-fluoromisonidazole PET and expression of HIF-1α and VEGF... | BeFree | 24781871 | Detail |
0.005 | Malignant glioma | In this study, we demonstrate the feasibility of combining adenovirus-mediated s... | BeFree | 25072110 | Detail |
0.005 | Malignant glioma | One of the important roles of IFN-β for malignant glioma growth inhibition was a... | BeFree | 25175315 | Detail |
0.005 | Malignant glioma | The vascular endothelial growth factor (VEGF)/VEGF receptor (VEGFR) signaling ca... | BeFree | 25353068 | Detail |
<0.001 | Cerebral metastasis | NA | BeFree | Detail | |
<0.001 | tongue carcinoma | NA | BeFree | Detail | |
<0.001 | Carotid Atherosclerosis | Production of IL-8, VEGF and Elastase by Circulating and Intraplaque Neutrophils... | BeFree | 25893670 | Detail |
0.008 | Osteosarcoma of bone | Autocrine VEGF/VEGFR1 signaling in a subpopulation of cells associates with aggr... | BeFree | 24759089 | Detail |
0.008 | Osteosarcoma of bone | CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angioge... | BeFree | 25330803 | Detail |
0.008 | Osteosarcoma of bone | A key role of microRNA-29b in suppression of osteosarcoma cell proliferation and... | BeFree | 25337211 | Detail |
0.008 | Osteosarcoma of bone | In the present study, we show that galectin-3 silencing in cultured human osteos... | BeFree | 25339127 | Detail |
0.008 | Osteosarcoma of bone | Our findings suggest a cooperative relationship between miR-410 and VEGF in OS c... | BeFree | 25385479 | Detail |
0.008 | Osteosarcoma of bone | Single nucleotide polymorphisms in VEGF gene are associated with an increased ri... | BeFree | 25550863 | Detail |
0.008 | Osteosarcoma of bone | Effect of polymorphisms of vascular endothelial growth factor on prognosis in os... | BeFree | 25966208 | Detail |
<0.001 | Intraocular pressure disorder | The present study aims to clarify the changes in conbercept levels, VEGF, and in... | BeFree | 25737631 | Detail |
0.002 | Aqueous Humor Disorders | The concentrations of PPARγ and vascular endothelial growth factor (VEGF) in the... | BeFree | 25468312 | Detail |
0.002 | Aqueous Humor Disorders | Compared with diabetic patients without ME, diabetic patients with ME had signif... | BeFree | 25923230 | Detail |
0.026 | Carcinogenesis | The vascular endothelial growth factor A (VEGF-A) is a potent proangiogenic agen... | BeFree | 24185122 | Detail |
0.026 | Carcinogenesis | It was concluded that BZG-4000 has the potential to inhibit the tumorigenesis of... | BeFree | 24632756 | Detail |
0.026 | Carcinogenesis | Kinase insert domain receptor (KDR) is the principal receptor that promotes the ... | BeFree | 25123269 | Detail |
0.026 | Carcinogenesis | +936C>T polymorphism of vascular endothelial growth factor (VEGF) is one of the ... | BeFree | 25335740 | Detail |
0.026 | Carcinogenesis | Structure-fluctuation-function relationships of seven pro-angiogenic isoforms of... | BeFree | 25617660 | Detail |
0.026 | Carcinogenesis | The vascular endothelial growth factor family has been implicated in tumorigenes... | BeFree | 25773840 | Detail |
0.003 | hyperhomocysteinemia | NA | BeFree,LHGDN | Detail | |
<0.001 | Leukemogenesis | NA | BeFree | Detail | |
<0.001 | Tumor Initiation | NA | BeFree | Detail | |
<0.001 | chronic interstitial cystitis | NA | BeFree | Detail | |
0.027 | prostate carcinoma | Associations of nm23H1, VEGF-C, and VEGF-3 receptor in human prostate cancer. | BeFree | 24858271 | Detail |
0.027 | prostate carcinoma | Vasoactive intestinal peptide (VIP) exerts similar effects in prostate cancer mo... | BeFree | 25446255 | Detail |
0.027 | prostate carcinoma | Adiponectin inhibits VEGF-A in prostate cancer cells. | BeFree | 25586350 | Detail |
0.002 | Hot flushes | NA | GAD | Detail | |
0.002 | hepatopulmonary syndrome | NA | GAD | Detail | |
0.202 | Choroidal Neovascularization | NA | CTD_human,GAD,RGD | Detail | |
<0.001 | Hashimoto Disease | NA | BeFree | Detail | |
0.014 | Epithelial ovarian cancer | Vascular endothelial growth factor (VEGF) polymorphism and increased risk of epi... | BeFree,GAD | 25092217 | Detail |
0.014 | Epithelial ovarian cancer | Serial sections of paraffin embedded ovarian tissues from 70 patients diagnosed ... | BeFree,GAD | 25163878 | Detail |
0.014 | Epithelial ovarian cancer | The median pretreatment serum VEGF and survivin levels in patients with serous o... | BeFree,GAD | 25577253 | Detail |
0.014 | Epithelial ovarian cancer | To assess the angiogenic properties of fibulin-4, vascular endothelial growth fa... | BeFree,GAD | 25885889 | Detail |
0.002 | Progressive Neoplastic Disease | Blood levels of MUC1 and VEGF mRNA at B0 and at B4w were significantly higher in... | BeFree | 25410981 | Detail |
0.002 | Progressive Neoplastic Disease | i) Serum VEGF levels were higher in patients with progressive disease than those... | BeFree | 25862879 | Detail |
<0.001 | Sentinel node (disorder) | NA | BeFree | Detail | |
<0.001 | Ewings sarcoma-primitive neuroectodermal tumor (PNET) | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of gastrointestinal tract | NA | BeFree | Detail | |
0.013 | Secondary malignant neoplasm of lymph node | The VEGF positive rate in patients at a later clinical stage was higher than tha... | BeFree | 25078598 | Detail |
0.013 | Secondary malignant neoplasm of lymph node | VEGF expression was significantly higher in hypopharyngeal squamous cell carcino... | BeFree | 25158264 | Detail |
0.013 | Secondary malignant neoplasm of lymph node | The present study aimed to investigate the expression patterns of HGF‑α and c‑Me... | BeFree | 25504327 | Detail |
0.013 | Secondary malignant neoplasm of lymph node | The positive expression of VEGF protein in cancer tissues with lymph node metast... | BeFree | 25624724 | Detail |
0.002 | Pregnancy loss | NA | GAD | Detail | |
0.021 | colon carcinoma | Biglycan up-regulated vascular endothelial growth factor (VEGF) expression and p... | BeFree | 25371074 | Detail |
0.021 | colon carcinoma | Of the gene-environment combined effects, the interaction of VEGF 1451C > T and ... | BeFree | 25423914 | Detail |
0.021 | colon carcinoma | This study showed that Lcn2-engineered MSCs (MSC-Lcn2) not only inhibited liver ... | BeFree | 25740061 | Detail |
0.021 | colon carcinoma | Interleukin-1 Receptor Type 2 Acts with c-Fos to Enhance the Expression of Inter... | BeFree | 26209639 | Detail |
0.027 | stomach carcinoma | In addition, ramucirumab, a monoclonal antibody targeting vascular endothelial g... | BeFree | 24744582 | Detail |
0.027 | stomach carcinoma | We performed a meta-analysis of individual patient data from six randomized phas... | BeFree | 25012543 | Detail |
0.027 | stomach carcinoma | Overexpression of different PFKFB in pancreatic and gastric cancer cells under h... | BeFree | 25320508 | Detail |
0.027 | stomach carcinoma | However, ramucirumab that targets VEGF receptor-2 prolonged overall survival in ... | BeFree | 25320512 | Detail |
0.027 | stomach carcinoma | Reduced miR-126 expression facilitates angiogenesis of gastric cancer through it... | BeFree | 25428912 | Detail |
0.027 | stomach carcinoma | Lymphangiogenesis is actively contributed to lymphatic metastasis in gastric can... | BeFree | 25444928 | Detail |
0.027 | stomach carcinoma | miR-874 functions as a tumor suppressor by inhibiting angiogenesis through STAT3... | BeFree | 25596740 | Detail |
0.027 | stomach carcinoma | SUZ12 siRNA inhibits the invasion of gastric carcinoma cells and the expression ... | BeFree | 25699394 | Detail |
0.027 | stomach carcinoma | Gastric cancer-associated enhancement of von Willebrand factor is regulated by v... | BeFree | 25886574 | Detail |
0.027 | stomach carcinoma | SUZ12 siRNA inhibits the invasion of gastric carcinoma cells and the expression ... | BeFree | 26176059 | Detail |
0.007 | Carcinoma of bladder | NA | BeFree | Detail | |
<0.001 | airway disease | NA | BeFree | Detail | |
0.010 | Central neuroblastoma | Interaction between bone marrow stromal cells and neuroblastoma cells leads to a... | BeFree | 25648303 | Detail |
0.010 | Central neuroblastoma | Gain- and loss-of-function studies indicated that secretory ITLN1 facilitated th... | BeFree | 25889839 | Detail |
<0.001 | Dissecting aneurysm of the thoracic aorta | NA | BeFree | Detail | |
<0.001 | Clinically significant macular edema | NA | BeFree | Detail | |
0.002 | diabetic macular edema | NA | BeFree | Detail | |
<0.001 | Microalbuminuria | NA | BeFree | Detail | |
<0.001 | Moderate chronic obstructive pulmonary disease | NA | BeFree | Detail | |
0.002 | Middle Cerebral Artery Occlusion | NA | BeFree | Detail | |
0.006 | Malignant neoplasm of kidney | NA | BeFree,GAD | Detail | |
<0.001 | allergic symptom | HIF-1alpha and vascular endothelial growth factor (VEGF) mRNA and protein expres... | BeFree | 24717944 | Detail |
0.001 | Refractory angina | NA | BeFree | Detail | |
<0.001 | Cardiac defects | NA | BeFree | Detail | |
<0.001 | irregular bleeding | NA | BeFree | Detail | |
<0.001 | Chronic lung disease | NA | BeFree | Detail | |
<0.001 | Acute myocardial ischemia | NA | BeFree | Detail | |
<0.001 | early pregnancy | Maternal plasma VEGF levels in early pregnancy were positively associated with s... | BeFree | 24718301 | Detail |
<0.001 | vascular disease occlusive | NA | BeFree | Detail | |
<0.001 | biliary tract cancer | NA | BeFree | Detail | |
<0.001 | Primary malignant neoplasm of brain | NA | BeFree | Detail | |
<0.001 | Frontotemporal Lobar Degeneration | NA | BeFree | Detail | |
<0.001 | Cancer of Digestive System | NA | BeFree | Detail | |
<0.001 | Well Differentiated Oligodendroglioma | NA | BeFree | Detail | |
<0.001 | Carotid Artery Plaque | NA | BeFree | Detail | |
<0.001 | Malignant Squamous Cell Neoplasm | NA | BeFree | Detail | |
<0.001 | peripheral nerve sheath neoplasm | NA | BeFree | Detail | |
0.001 | malignant peripheral nerve sheath tumor | The pathological diagnosis of malignant schwannoma indicated that the p53 expres... | BeFree | 26146864 | Detail |
<0.001 | brain infarction | NA | BeFree | Detail | |
<0.001 | Multiple Sclerosis, Secondary Progressive | NA | BeFree | Detail | |
<0.001 | Multiple Sclerosis, Relapsing-Remitting | NA | BeFree | Detail | |
<0.001 | spinocerebellar ataxia type 1 | NA | BeFree | Detail | |
0.120 | Hypoxia-Ischemia, Brain | NA | CTD_human | Detail | |
<0.001 | Lewy Body Disease | Reduced vascular endothelial growth factor and capillary density in the occipita... | BeFree | 24521289 | Detail |
<0.001 | malignant pleural mesothelioma | NA | BeFree | Detail | |
<0.001 | In situ cancer | NA | BeFree | Detail | |
0.002 | Pregnancy associated hypertension | NA | GAD | Detail | |
0.005 | Respiratory Distress Syndrome | NA | GAD | Detail | |
<0.001 | Arteriopathic disease | NA | BeFree | Detail | |
<0.001 | Invasive breast carcinoma | NA | BeFree | Detail | |
<0.001 | Rhabdoid Tumor of the Kidney | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of lung, stage I | NA | BeFree | Detail | |
<0.001 | placental choriocarcinoma | In addition, miR-126 overexpression significantly upregulated VEGF expression in... | BeFree | 25341970 | Detail |
0.002 | Endothelial dysfunction | In this review, we focus on the main genes that are epigenetically modified duri... | BeFree | 25433555 | Detail |
<0.001 | Acute GVH disease | NA | BeFree | Detail | |
<0.001 | Lung cancer stage I | NA | BeFree | Detail | |
<0.001 | Allergic skin reaction | Leucocyte infiltration with vascular leakage and expression of the potent vasoac... | BeFree | 24902612 | Detail |
<0.001 | Hepatoma resectable | NA | BeFree | Detail | |
<0.001 | Chronic graft-versus-host disease | NA | BeFree | Detail | |
<0.001 | Advanced cancer | NA | BeFree | Detail | |
<0.001 | Carcinomatous ascites | NA | BeFree | Detail | |
<0.001 | Intraepithelial Neoplasia | NA | BeFree | Detail | |
0.001 | Cardiomyopathies | NA | BeFree | Detail | |
0.003 | Stromal Neoplasm | NA | BeFree | Detail | |
0.120 | Carcinoma, Pancreatic Ductal | NA | BeFree,CTD_human | Detail | |
0.003 | Cerebral Ischemia | NA | BeFree | Detail | |
<0.001 | Arteriovenous Malformations, Cerebral | NA | BeFree | Detail | |
0.031 | ovarian neoplasm | NA | BeFree,LHGDN | Detail | |
<0.001 | Renal cancer metastatic | NA | BeFree | Detail | |
<0.001 | cancer recurrence | NA | BeFree | Detail | |
<0.001 | myocardial hypoxia | NA | BeFree | Detail | |
<0.001 | Metastatic Prostate Carcinoma | NA | BeFree | Detail | |
<0.001 | chondroma | NA | BeFree | Detail | |
<0.001 | precancerous lesions | NA | BeFree | Detail | |
0.001 | Ischemic stroke | NA | BeFree | Detail | |
<0.001 | Acute coronary syndrome | NA | BeFree | Detail | |
0.009 | Colorectal cancer metastatic | In this way, the anti-VEGF antibody bevacizumab in combination with chemotherapy... | BeFree | 24793846 | Detail |
0.009 | Colorectal cancer metastatic | The VEGF- (bevacizumab) and EGFR- (cetuximab and panitumumab) targeting monoclon... | BeFree | 25531050 | Detail |
0.009 | Colorectal cancer metastatic | Vascular Endothelial Growth Factor A c.*237C>T polymorphism is associated with b... | BeFree | 25617075 | Detail |
0.009 | Colorectal cancer metastatic | Second-line treatment with chemotherapy and anti-epidermal growth factor recepto... | BeFree | 25982297 | Detail |
0.009 | Colorectal cancer metastatic | Ninety-six somatic mutations in key oncogenic drivers of mCRC and 133 common sin... | BeFree | 26355232 | Detail |
0.001 | Denys-Drash syndrome | NA | BeFree | Detail | |
0.001 | Arthritis, Collagen-Induced | We sought to determine the relevance of these findings to autoimmunity because e... | BeFree | 25475856 | Detail |
0.120 | Arthritis, Experimental | NA | CTD_human | Detail | |
<0.001 | Vascular occlusion | NA | BeFree | Detail | |
0.002 | Invasive Ductal Breast Carcinoma | NA | BeFree | Detail | |
<0.001 | Stage 4S neuroblastoma | NA | BeFree | Detail | |
0.041 | Malignant neoplasm of ovary | MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth fa... | BeFree,GAD | 25176450 | Detail |
0.041 | Malignant neoplasm of ovary | These results suggested that VEGF could impact ovarian cancer's malignant progre... | BeFree,GAD | 25192722 | Detail |
0.041 | Malignant neoplasm of ovary | Our data reveal a new potential pathway in which VEGF promotes the invasion of o... | BeFree,GAD | 25597268 | Detail |
0.041 | Malignant neoplasm of ovary | IKKβ Regulates VEGF Expression and Is a Potential Therapeutic Target for Ovarian... | BeFree,GAD | 25637316 | Detail |
0.001 | endometrial adenocarcinoma | NA | BeFree | Detail | |
0.007 | Squamous cell carcinoma of the head and neck | PC7 (PCSK7) and furin siRNAs upregulated HIF-1α protein under normoxic condition... | BeFree | 24436242 | Detail |
0.007 | Squamous cell carcinoma of the head and neck | We found that garcinol inhibited the viability of a panel of diverse HNSCC cell ... | BeFree | 25762616 | Detail |
0.006 | Ductal Carcinoma | NA | BeFree,LHGDN | Detail | |
<0.001 | Barrett Epithelium | NA | BeFree | Detail | |
0.002 | Myxoid cyst | NA | BeFree | Detail | |
<0.001 | Abnormal breathing | NA | BeFree | Detail | |
<0.001 | Drusen | NA | BeFree | Detail | |
0.005 | Stenosis | NA | LHGDN | Detail | |
0.017 | sarcoma | NA | BeFree,LHGDN | Detail | |
0.080 | attention deficit hyperactivity disorder | NA | RGD | Detail | |
<0.001 | chromophobe renal cell carcinoma | NA | BeFree | Detail | |
0.003 | major depressive disorder | Vascular endothelial growth factor A gene expression level is higher in patients... | BeFree,GAD | 24718046 | Detail |
<0.001 | Mild cognitive disorder | NA | BeFree | Detail | |
<0.001 | Choroidal neovascular membrane (disorder) | VEGF-A165 and VEGF-A189 are significantly higher in CNV than in control choroids... | BeFree | 25494018 | Detail |
<0.001 | Degenerative disorder | NA | BeFree | Detail | |
0.001 | Inflammatory disorder | Previous research has indicated that modified VEGF-VEGFR signaling pathway has a... | BeFree | 25641412 | Detail |
0.004 | Primary Effusion Lymphoma | Targeting VEGF and interleukin-6 for controlling malignant effusion of primary e... | BeFree,LHGDN | 25304617 | Detail |
<0.001 | Precursor B-cell lymphoblastic leukemia | NA | BeFree | Detail | |
<0.001 | Chronic myeloproliferative disorder | NA | BeFree | Detail | |
<0.001 | Radial scar | NA | BeFree | Detail | |
<0.001 | Necrotic tumor | NA | BeFree | Detail | |
0.002 | Adenoma of large intestine | NA | BeFree | Detail | |
0.003 | Hepatic Insufficiency | NA | LHGDN | Detail | |
<0.001 | Peripheral arterial occlusive disease | NA | BeFree | Detail | |
<0.001 | Astrocytoma, low grade | NA | BeFree | Detail | |
<0.001 | Liver regeneration disorder | In the in vitro experiments, LPS preconditioning of ASCs enhanced the mRNA expre... | BeFree | 25890074 | Detail |
<0.001 | M5b Acute differentiated monocytic leukemia | NA | BeFree | Detail | |
0.002 | Adenocarcinoma of large intestine | C936T polymorphism of the VEGF gene in relation to the risk and the clinical and... | BeFree | 25361753 | Detail |
<0.001 | pancreatic endocrine carcinoma | NA | BeFree | Detail | |
<0.001 | Classical Hodgkin's Lymphoma | NA | BeFree | Detail | |
<0.001 | High Grade Cervical Intraepithelial Neoplasia | NA | BeFree | Detail | |
<0.001 | Infiltrating Cervical Carcinoma | NA | BeFree | Detail | |
<0.001 | Invasive Carcinoma | NA | BeFree | Detail | |
<0.001 | maxillary sinus squamous cell carcinoma | NA | BeFree | Detail | |
<0.001 | Non-Hereditary Clear Cell Renal Cell Carcinoma | NA | BeFree | Detail | |
0.002 | pancreatic ductal adenocarcinoma | VEGF, PDGF, FGF and their receptors are expressed at high levels and correlate w... | BeFree | 25527450 | Detail |
<0.001 | Pericytic Neoplasm | NA | BeFree | Detail | |
0.001 | Sporadic Breast Carcinoma | NA | BeFree | Detail | |
<0.001 | Carcinoma of urinary bladder, superficial | NA | BeFree | Detail | |
<0.001 | Endometrial Endometrioid Adenocarcinoma | NA | BeFree | Detail | |
0.001 | differentiated thyroid gland carcinoma | Targeting vascular endothelial growth factor (VEGF) pathway in iodine-refractory... | BeFree | 25560732 | Detail |
<0.001 | xanthogranulomatous cholecystitis | NA | BeFree | Detail | |
0.002 | Epithelioma | NA | BeFree | Detail | |
<0.001 | Undifferentiated leukemia | NA | BeFree | Detail | |
0.005 | renal carcinoma | NA | BeFree | Detail | |
<0.001 | Generalized osteoarthritis | NA | BeFree | Detail | |
<0.001 | Cardiac fibrosis | NA | BeFree | Detail | |
<0.001 | Cardiomyopathy, Familial Idiopathic | NA | BeFree | Detail | |
<0.001 | Diabetic foot ulcer | NA | BeFree | Detail | |
0.092 | Mammary Neoplasms | The ShcA adaptor activates AKT signaling to potentiate breast tumor angiogenesis... | BeFree,GAD,LHGDN | 24837366 | Detail |
0.092 | Mammary Neoplasms | OPN also regulates hypoxia-inducible factor-1α-dependent VEGF expression leading... | BeFree,GAD,LHGDN | 24899149 | Detail |
0.004 | Angiogenic Switch | NA | BeFree | Detail | |
<0.001 | Breast Cancer Model | NA | BeFree | Detail | |
<0.001 | grade II meningioma | NA | BeFree | Detail | |
<0.001 | Cervical high grade squamous intraepithelial lesion | NA | BeFree | Detail | |
<0.001 | Mammary Tumorigenesis | These findings establish ShcA as a biological bridge that links AKT activation d... | BeFree | 24837366 | Detail |
<0.001 | Primary Peritoneal Carcinoma | NA | BeFree | Detail | |
<0.001 | Cancer Cell Growth | Hypoxia stimulates several pathways that are critical to cancer cell growth and ... | BeFree | 24972565 | Detail |
<0.001 | Cancer Cell Growth | Furthermore, the effects of VEGFa-induced activation of mTor signaling cascades ... | BeFree | 25135429 | Detail |
<0.001 | Skin Carcinogenesis | NA | BeFree | Detail | |
0.003 | Tumor-Associated Vasculature | NA | BeFree | Detail | |
0.080 | Tumor Angiogenesis | In conclusion, MTA1 is a potent angiogenic molecule and cross talk between VEGF ... | BeFree | 24265228 | Detail |
0.080 | Tumor Angiogenesis | To investigate the inhibitory effect of Coptidis rhizome aqueous extract (CRAE) ... | BeFree | 24363282 | Detail |
0.080 | Tumor Angiogenesis | In addition to interrogating the effect of gene knockdown in endothelial cells, ... | BeFree | 24759702 | Detail |
0.080 | Tumor Angiogenesis | MMP9 also enhances PKD2-mediated tumor angiogenesis releasing extracellular matr... | BeFree | 24847910 | Detail |
0.080 | Tumor Angiogenesis | Collectively, we discovered a miR-361-5p/VEGF-dependent regulation that could he... | BeFree | 24865854 | Detail |
0.080 | Tumor Angiogenesis | Western Blot and immunohistochemistry staining showed that Ad5/F35-XAF1 treatmen... | BeFree | 24980821 | Detail |
0.080 | Tumor Angiogenesis | Of the 102 stage I NSCLC specimens analyzed, high RBP2 protein expression is clo... | BeFree | 25162518 | Detail |
0.080 | Tumor Angiogenesis | Survivin expression promotes VEGF-induced tumor angiogenesis via PI3K/Akt enhanc... | BeFree | 25204429 | Detail |
0.080 | Tumor Angiogenesis | CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angioge... | BeFree | 25330803 | Detail |
0.080 | Tumor Angiogenesis | TARAP was found to suppress the expression of vascular endothelial growth factor... | BeFree | 25333354 | Detail |
0.080 | Tumor Angiogenesis | The vascular endothelial growth factor (VEGF)/VEGF receptor (VEGFR) signaling ca... | BeFree | 25353068 | Detail |
0.080 | Tumor Angiogenesis | Taken together, our results indicated that biglycan up-regulated VEGF expression... | BeFree | 25371074 | Detail |
0.080 | Tumor Angiogenesis | Moreover, F2 suppressed vascular endothelial growth factor (VEGF) and matrix met... | BeFree | 25385044 | Detail |
0.080 | Tumor Angiogenesis | The major mediator of tumor angiogenesis is VEGF-A, frequently referred to as VE... | BeFree | 25560472 | Detail |
0.080 | Tumor Angiogenesis | It mediates downstream hypoxia-inducible factor 1α accumulation in the nucleus, ... | BeFree | 25579062 | Detail |
0.080 | Tumor Angiogenesis | RhoC protein may upregulate VEGF expression, thereby promoting tumor angiogenesi... | BeFree | 25624724 | Detail |
0.080 | Tumor Angiogenesis | Evidence is accumulating that activation of the pancreatic endoplasmic reticulum... | BeFree | 25794107 | Detail |
0.080 | Tumor Angiogenesis | Consistent with these data, RdB/FP3 was shown to greatly decrease VEGF expressio... | BeFree | 25944623 | Detail |
0.080 | Tumor Angiogenesis | Antiangiogenic VEGF-Ax: A New Participant in Tumor Angiogenesis. | BeFree | 26122849 | Detail |
0.080 | Tumor Angiogenesis | They can modulate pro-angiogenic signals induced by vascular endothelial growth ... | BeFree | 26144623 | Detail |
<0.001 | Tumor Expansion | Vascular endothelial growth factor (VEGF) was considered as a critical growth fa... | BeFree | 25577246 | Detail |
<0.001 | Tumor Promotion | Growth-stimulating effects of ERβ may be due in part to downstream actions that ... | BeFree | 25874233 | Detail |
0.005 | Xenograft Model | Gene transfection and silencing, and antitumor effect of the At-Lp loaded with V... | BeFree | 25039617 | Detail |
0.005 | Xenograft Model | Consequently, genetic or pharmacologic inhibition of integrin αvβ3 decreased VEG... | BeFree | 25488971 | Detail |
0.005 | Xenograft Model | Finally, we demonstrate for the first time that curcumin analogues EF31 and UBS1... | BeFree | 25497868 | Detail |
0.005 | Xenograft Model | In a xenograft model, the treatment of IMD-0354 significantly inhibited peritone... | BeFree | 25637316 | Detail |
0.054 | colorectal cancer | Constant development of chemotherapy and more recently the introduction of VEGF-... | BeFree,GAD | 24727985 | Detail |
0.054 | colorectal cancer | We analyzed VEGF (-2578C>A, -1498C>T, -1154G>A, -634C>G, +936C>T) and eNOS (+894... | BeFree,GAD | 25079441 | Detail |
0.054 | colorectal cancer | Association between EGF and VEGF functional polymorphisms and sporadic colorecta... | BeFree,GAD | 25117311 | Detail |
0.054 | colorectal cancer | These results indicate that alternative splicing of an RNA binding protein can r... | BeFree,GAD | 25224594 | Detail |
0.054 | colorectal cancer | VEGF IHC positivity was significantly more common in patients with high expressi... | BeFree,GAD | 25422250 | Detail |
0.054 | colorectal cancer | Interplay between 3'-UTR polymorphisms in the vascular endothelial growth factor... | BeFree,GAD | 25423914 | Detail |
0.054 | colorectal cancer | The molecular targets of CRC include at least two important cell surface recepto... | BeFree,GAD | 25561783 | Detail |
0.054 | colorectal cancer | We found that FIH-1 was able to inhibit HIF1α mediated transcription of GLUT1 an... | BeFree,GAD | 25602156 | Detail |
0.054 | colorectal cancer | To characterize the population pharmacokinetics of bevacizumab, its binding prop... | BeFree,GAD | 25687989 | Detail |
0.054 | colorectal cancer | Serum cytokine levels in patients with colorectal cancers according to tumor sta... | BeFree,GAD | 25713884 | Detail |
0.054 | colorectal cancer | Furthermore, the expression level of excision repair cross-complementation group... | BeFree,GAD | 26031756 | Detail |
0.087 | brain edema | NA | BeFree,LHGDN,RGD | Detail | |
<0.001 | Ductal Breast Carcinoma | NA | BeFree | Detail | |
<0.001 | Neoplasms, Intracranial | NA | BeFree | Detail | |
<0.001 | smoldering myeloma | NA | BeFree | Detail | |
<0.001 | cancer angiogenesis | NA | BeFree | Detail | |
0.002 | Rash and Dermatitis Adverse Event Associated with Chemoradiation | NA | BeFree | Detail | |
0.006 | Non-Malignant Ascites Adverse Event | In a PEL xenograft mouse model that showed profuse ascites, bevacizumab suppress... | BeFree | 25304617 | Detail |
0.006 | Non-Malignant Ascites Adverse Event | Levels of lipopolysaccharide-binding protein in plasma and highly sensitive C-re... | BeFree | 25357217 | Detail |
0.001 | Chronic Kidney Diseases | NA | BeFree | Detail | |
<0.001 | Warm Ischemia | NA | BeFree | Detail | |
<0.001 | Tendinosis | NA | BeFree | Detail | |
0.003 | Glioblastoma multiforme | AAVrh.10BevMab, an AAVrh.10-based vector coding for bevacizumab (Avastin), an an... | BeFree | 25501993 | Detail |
0.002 | Cirrhosis | NA | BeFree | Detail | |
<0.001 | Macular dystrophy, corneal type 1 | NA | BeFree | Detail | |
0.005 | tumor vasculature | Targeting angiogenesis by inhibition of vascular endothelial growth factor (VEGF... | BeFree | 25340839 | Detail |
<0.001 | Benign Prostatic Hyperplasia | NA | BeFree | Detail | |
<0.001 | Glomerulonephritis, Minimal Change | NA | BeFree | Detail | |
<0.001 | Uterine Corpus Carcinosarcoma | NA | BeFree | Detail | |
<0.001 | Milroy Disease | NA | BeFree | Detail | |
0.006 | Peripheral Arterial Diseases | In univariate analysis, a significantly increased risk for development of AAA wi... | BeFree | 24657063 | Detail |
0.006 | Peripheral Arterial Diseases | These findings demonstrate that PKR mediates angiogenesis through a VEGF pathway... | BeFree | 25587101 | Detail |
<0.001 | Invasive Skin Melanoma | NA | BeFree | Detail | |
<0.001 | Non-Neoplastic Disorder | NA | BeFree | Detail | |
<0.001 | sinonasal undifferentiated carcinoma | NA | BeFree | Detail | |
0.003 | Testicular Hydrocele | NA | BeFree,GAD | Detail | |
0.001 | Meningioma, benign, no ICD-O subtype | Hypoxia inducible factor-1 is involved in growth factor, glucocorticoid and hypo... | BeFree | 24980036 | Detail |
0.004 | Idiopathic Pulmonary Fibrosis | NA | BeFree,GAD | Detail | |
<0.001 | Bulbo-Spinal Atrophy, X-Linked | NA | BeFree | Detail | |
<0.001 | MULTICYSTIC RENAL DYSPLASIA, BILATERAL | NA | BeFree | Detail | |
<0.001 | Mammographic Density | NA | BeFree | Detail | |
0.001 | Myeloproliferative disorder, chronic, with eosinophilia | NA | BeFree | Detail | |
<0.001 | BREAST CANCER 3 | NA | BeFree | Detail | |
<0.001 | Vohwinkel Syndrome, Variant Form | NA | BeFree | Detail | |
0.001 | ABLEPHARON-MACROSTOMIA SYNDROME | NA | BeFree | Detail | |
<0.001 | DOWN SYNDROME CRITICAL REGION | NA | BeFree | Detail | |
<0.001 | stiff skin syndrome | NA | BeFree | Detail | |
0.080 | AMYOTROPHIC LATERAL SCLEROSIS 1 | NA | MGD | Detail | |
0.006 | uterine corpus cancer | Alterations of angiogenic factors including angiotensin (AngII) or VEGF are obse... | BeFree | 25231075 | Detail |
0.006 | uterine corpus cancer | We assessed the safety and activity of dovitinib, a potent tyrosine-kinase inhib... | BeFree | 25981814 | Detail |
<0.001 | Extranodal marginal zone B-cell lymphoma | NA | BeFree | Detail | |
0.150 | coronary artery disease | Dysregulated miR-361-5p/VEGF axis in the plasma and endothelial progenitor cells... | BeFree,CTD_human,GAD,LHGDN | 24865854 | Detail |
0.150 | coronary artery disease | In addition, VEGF serum levels were analyzed in 98 subjects with type 2 diabetes... | BeFree,CTD_human,GAD,LHGDN | 25128838 | Detail |
0.001 | Angioma | NA | BeFree | Detail | |
0.006 | Precursor Cell Lymphoblastic Leukemia Lymphoma | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Congenital vascular anomaly | NA | BeFree | Detail | |
0.080 | Respiratory Distress Syndrome In Premature Infants | NA | MGD | Detail | |
<0.001 | Total retinal detachment | NA | BeFree | Detail | |
0.001 | Urothelial Carcinoma | Gene expression of STAT3, NF-κB, TGFβ1, cyclin D1 and VEGFA was measured by quan... | BeFree | 24448750 | Detail |
0.094 | liver carcinoma | Suppression of vascular endothelial growth factor via inactivation of eukaryotic... | BeFree,GAD,LHGDN | 24363282 | Detail |
0.094 | liver carcinoma | Silencing alpha-fetoprotein inhibits VEGF and MMP-2/9 production in human hepato... | BeFree,GAD,LHGDN | 24587407 | Detail |
0.094 | liver carcinoma | It was concluded that BZG-4000 has the potential to inhibit the tumorigenesis of... | BeFree,GAD,LHGDN | 24632756 | Detail |
0.094 | liver carcinoma | Expression characteristics of KAI1 and vascular endothelial growth factor and th... | BeFree,GAD,LHGDN | 25071074 | Detail |
0.094 | liver carcinoma | Kinase insert domain receptor (KDR) is the principal receptor that promotes the ... | BeFree,GAD,LHGDN | 25123269 | Detail |
0.094 | liver carcinoma | Tube formation of HUVECs was assessed with an ECMatrix gel system, and mRNA and ... | BeFree,GAD,LHGDN | 25148840 | Detail |
0.094 | liver carcinoma | The goal of this study was to determine the interaction between CD105 and VEGF i... | BeFree,GAD,LHGDN | 25286761 | Detail |
0.094 | liver carcinoma | Our results showed that conditional medium from co-culture of HCC/HSCs induced V... | BeFree,GAD,LHGDN | 25326336 | Detail |
0.094 | liver carcinoma | Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular e... | BeFree,GAD,LHGDN | 25328135 | Detail |
0.094 | liver carcinoma | In conclusion, the present study suggests that hypoxia-induced PDGF-BB secretion... | BeFree,GAD,LHGDN | 25333351 | Detail |
0.094 | liver carcinoma | Polymorphisms of vascular endothelial growth factor on prognosis in hepatocellul... | BeFree,GAD,LHGDN | 25366785 | Detail |
0.094 | liver carcinoma | γ-H2AX knockdown was able to effectively inhibit VEGF expression in vitro and tu... | BeFree,GAD,LHGDN | 25537504 | Detail |
0.094 | liver carcinoma | After hepatoma, cells were transfected with shRNA, GPC-3 expression or prolifera... | BeFree,GAD,LHGDN | 25553423 | Detail |
0.094 | liver carcinoma | microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pat... | BeFree,GAD,LHGDN | 25608619 | Detail |
0.094 | liver carcinoma | This study suggested that chronic moderate alcohol consumption may promote the p... | BeFree,GAD,LHGDN | 25622857 | Detail |
0.094 | liver carcinoma | The aim of this study was to investigate the effects of the vascular endothelial... | BeFree,GAD,LHGDN | 25730004 | Detail |
0.094 | liver carcinoma | VEGF in patients with advanced hepatocellular carcinoma receiving intra-arterial... | BeFree,GAD,LHGDN | 25862879 | Detail |
0.094 | liver carcinoma | Lysyl Oxidase Is Predictive of Unfavorable Outcomes and Essential for Regulation... | BeFree,GAD,LHGDN | 26048020 | Detail |
0.002 | Chronic kidney disease stage 5 | NA | BeFree | Detail | |
0.080 | Periodontal Atrophy | NA | RGD | Detail | |
0.003 | T-cell prolymphocytic leukemia | NA | BeFree,LHGDN | Detail | |
<0.001 | Chronic thromboembolic pulmonary hypertension | NA | BeFree | Detail | |
<0.001 | Allergic rhinitis (disorder) | HIF-1alpha and VEGF expression increased in the nasal mucosa of patients with AR... | BeFree | 24717944 | Detail |
0.120 | Acute kidney injury | NA | CTD_human | Detail | |
<0.001 | Metastatic Ductal Breast Carcinoma | NA | BeFree | Detail | |
0.121 | Thrombotic Microangiopathies | NA | BeFree,CTD_human | Detail | |
<0.001 | Alcoholic Steatohepatitis | NA | BeFree | Detail | |
<0.001 | Kashin-Beck Disease | NA | BeFree | Detail | |
<0.001 | AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED | NA | BeFree | Detail | |
0.002 | Infection of amniotic sac and membranes, unspecified, unspecified trimester, not applicable or unspecified | NA | GAD | Detail | |
<0.001 | Cavernous Hemangioma of Brain | NA | BeFree | Detail | |
<0.001 | Moyamoya disease 1 | NA | BeFree | Detail | |
0.008 | Nasopharyngeal carcinoma | Compared with vector-alone control cells, BLU stable transfectants, derived from... | BeFree,GAD | 25347745 | Detail |
0.001 | Clear-cell metastatic renal cell carcinoma | NA | BeFree | Detail | |
0.120 | Cerebral Hemorrhage | NA | CTD_human | Detail | |
0.005 | Prostatic Hyperplasia | NA | LHGDN | Detail | |
0.007 | limb ischemia | Pre-clinical studies and Phase I clinical trials using VEGF and fibroblast growt... | BeFree | 25633211 | Detail |
0.001 | Pulmonary arterial hypertension | Administration of BMP9 reversed established PAH in these mice, as well as in two... | BeFree | 26076038 | Detail |
<0.001 | Ocular Adnexal Lymphoma | NA | BeFree | Detail | |
<0.001 | Early-Stage Breast Carcinoma | NA | BeFree | Detail | |
<0.001 | Stage III Colon Cancer AJCC v7 | NA | BeFree | Detail | |
<0.001 | Stage II Colon Cancer AJCC v7 | NA | BeFree | Detail | |
<0.001 | Tumor thrombus | NA | BeFree | Detail | |
<0.001 | Idiopathic pulmonary arterial hypertension | NA | BeFree | Detail | |
<0.001 | Three Vessel Coronary Disease | NA | BeFree | Detail | |
0.001 | Ischemic Cerebrovascular Accident | NA | BeFree | Detail | |
0.002 | Spontaneous abortion, recurrent | NA | GAD | Detail | |
0.005 | myelodysplastic syndrome | NA | LHGDN | Detail | |
0.003 | Juvenile arthritis | NA | BeFree,LHGDN | Detail | |
0.002 | Progressive cGVHD | Blood levels of MUC1 and VEGF mRNA at B0 and at B4w were significantly higher in... | BeFree | 25410981 | Detail |
0.002 | Progressive cGVHD | i) Serum VEGF levels were higher in patients with progressive disease than those... | BeFree | 25862879 | Detail |
0.003 | Triple Negative Breast Neoplasms | Treatment of TNBC cell lines with dutasteride was associated with a dose-depende... | BeFree | 25356777 | Detail |
0.003 | Triple Negative Breast Neoplasms | We investigated the therapeutic impact of a vaccinia virus (VACV) GLV-1h164 (der... | BeFree | 25391896 | Detail |
0.003 | Triple Negative Breast Neoplasms | We have previously shown that vascular endothelial growth factor (VEGF) expressi... | BeFree | 25449683 | Detail |
0.003 | Triple Negative Breast Neoplasms | Transforming growth factor-β, insulin-like growth factor I/insulin-like growth f... | BeFree | 25824321 | Detail |
0.003 | Triple Negative Breast Neoplasms | VEGF-A, IGF-I and IGF-IR play an important role in the development and progressi... | BeFree | 26232605 | Detail |
<0.001 | aortic valve disease 2 | NA | BeFree | Detail | |
<0.001 | Basal-Like Breast Carcinoma | Our results support that osteopontin regulates ICAM-1 and VEGFA expression mainl... | BeFree | 25972323 | Detail |
<0.001 | Unspecified visual loss | NA | BeFree | Detail | |
<0.001 | Intracranial glioma | NA | BeFree | Detail | |
0.011 | Infection | NA | GAD,LHGDN | Detail | |
<0.001 | Fibromyxosarcoma | NA | BeFree | Detail | |
<0.001 | Pneumonitis | NA | BeFree | Detail | |
<0.001 | juvenile rheumatoid arthritis | NA | BeFree | Detail | |
0.001 | Pulmonary hypertension, primary, 1, with hereditary hemorrhagic telangiectasia | Administration of BMP9 reversed established PAH in these mice, as well as in two... | BeFree | 26076038 | Detail |
<0.001 | GRN-related frontotemporal dementia | NA | BeFree | Detail | |
0.002 | Congenital Abnormality | NA | BeFree | Detail | |
0.002 | Spontaneous abortion | NA | GAD | Detail | |
0.003 | Abortion, Habitual | NA | LHGDN | Detail | |
<0.001 | acromegaly | NA | BeFree | Detail | |
0.048 | adenocarcinoma | VEGF neutralizing aerosol therapy in primary pulmonary adenocarcinoma with K-ras... | BeFree,GAD,LHGDN | 25484066 | Detail |
0.048 | adenocarcinoma | Especially, VEGFA over-expression was an independent prognostic factor in adenoc... | BeFree,GAD,LHGDN | 25773840 | Detail |
0.002 | papillary adenocarcinoma | NA | GAD | Detail | |
0.021 | colon carcinoma | After stratifying by tumor molecular subtype, SNP associations observed for colo... | BeFree | 23794399 | Detail |
0.009 | adenoma | NA | BeFree,LHGDN | Detail | |
0.018 | Malignant tumor of colon | After stratifying by tumor molecular subtype, SNP associations observed for colo... | BeFree | 23794399 | Detail |
0.003 | Tumors of Adrenal Cortex | NA | LHGDN | Detail | |
0.004 | Primary myelofibrosis | NA | BeFree,LHGDN | Detail | |
0.005 | Albuminuria | NA | GAD,LHGDN | Detail | |
0.006 | Altitude Sickness | NA | BeFree,GAD,LHGDN | Detail | |
0.239 | Colonic Neoplasms | After stratifying by tumor molecular subtype, SNP associations observed for colo... | BeFree | 23794399 | Detail |
0.148 | Alzheimer's disease | The excess vascular endothelial growth factor (VEGF) produced in the Alzheimer's... | BeFree,CTD_human,GAD,LHGDN | 24948534 | Detail |
<0.001 | amyloidosis | NA | BeFree | Detail | |
0.027 | amyotrophic lateral sclerosis | NA | BeFree,LHGDN | Detail | |
<0.001 | Anaplasia | NA | BeFree | Detail | |
0.003 | anemia | VEGFR2-mediated vascular dilation as a mechanism of VEGF-induced anemia and bone... | BeFree,LHGDN | 25310988 | Detail |
0.001 | Anemia, Sickle Cell | NA | BeFree | Detail | |
<0.001 | Aneurysm | NA | BeFree | Detail | |
0.002 | Angina Pectoris | NA | GAD | Detail | |
<0.001 | Angina, Unstable | NA | BeFree | Detail | |
<0.001 | angiokeratoma | NA | BeFree | Detail | |
<0.001 | Fabry disease | NA | BeFree | Detail | |
<0.001 | aniridia | NA | BeFree | Detail | |
0.030 | Anoxia | NA | LHGDN | Detail | |
<0.001 | aortic aneurysm | This study identifies polymorphisms in the HIF1A and VEGF genes as potential gen... | BeFree | 24657063 | Detail |
<0.001 | Arterial Occlusive Diseases | NA | BeFree | Detail | |
0.007 | arteriosclerosis | This study identifies polymorphisms in the HIF1A and VEGF genes as potential gen... | BeFree | 24657063 | Detail |
0.007 | arteriosclerosis | The role of miR-26a in atherosclerosis is mediated by its target EphA2 via a mec... | BeFree | 25613580 | Detail |
0.003 | arteriosclerosis obliterans | NA | LHGDN | Detail | |
0.081 | Arteriovenous fistula | There is an increased risk of AV fistula thrombosis in individuals carrying the ... | BeFree,RGD | 24748065 | Detail |
0.081 | Arteriovenous fistula | The outflow vein was removed three days following the creation of the AVF and ge... | BeFree,RGD | 25036043 | Detail |
0.005 | Congenital arteriovenous malformation | Cultured AVMECs expressed higher angiogenic factors (VEGF, MMP-2) than the contr... | BeFree,LHGDN | 24771337 | Detail |
0.005 | arthritis | NA | BeFree,LHGDN | Detail | |
0.003 | Arthritis, Psoriatic | NA | BeFree,GAD | Detail | |
0.144 | rheumatoid arthritis | Arthritic synovial tissues from patients with rheumatoid arthritis (RA) or osteo... | BeFree,CTD_human,GAD,LHGDN | 25483913 | Detail |
0.005 | Ascites | NA | GAD,LHGDN | Detail | |
<0.001 | asphyxia neonatorum | NA | BeFree | Detail | |
0.148 | asthma | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
0.014 | Astrocytoma | NA | BeFree,LHGDN | Detail | |
0.147 | atherosclerosis | This study identifies polymorphisms in the HIF1A and VEGF genes as potential gen... | BeFree,CTD_human,GAD,LHGDN | 24657063 | Detail |
0.147 | atherosclerosis | The role of miR-26a in atherosclerosis is mediated by its target EphA2 via a mec... | BeFree,CTD_human,GAD,LHGDN | 25613580 | Detail |
0.002 | autistic disorder | NA | GAD | Detail | |
<0.001 | Bacterial Infections | NA | BeFree | Detail | |
<0.001 | Barrett esophagus | NA | BeFree | Detail | |
0.002 | Basal Ganglia Diseases | NA | GAD | Detail | |
0.011 | Behcet Syndrome | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | biliary atresia | NA | BeFree | Detail | |
0.002 | Biliary Tract Neoplasm | NA | GAD | Detail | |
0.015 | Malignant neoplasm of urinary bladder | NA | BeFree,GAD | Detail | |
0.010 | Bladder Neoplasm | NA | BeFree,LHGDN | Detail | |
<0.001 | Blast Phase | In conclusion, CML in blast crisis had increased levels of CECs and VEGF gene ex... | BeFree | 25831205 | Detail |
0.001 | borderline personality disorder | NA | BeFree | Detail | |
0.130 | Brain Neoplasms | NA | BeFree,CTD_human,LHGDN | Detail | |
0.003 | bronchitis | NA | BeFree,LHGDN | Detail | |
0.004 | bronchopulmonary dysplasia | Our evidence also suggests that the VEGF pathway and downstream NFKB signaling m... | BeFree,GAD | 24874013 | Detail |
0.003 | Cachexia | NA | LHGDN | Detail | |
<0.001 | Carcinoid Tumor | NA | BeFree | Detail | |
0.018 | Malignant tumor of colon | Biglycan up-regulated vascular endothelial growth factor (VEGF) expression and p... | BeFree | 25371074 | Detail |
0.018 | Malignant tumor of colon | Of the gene-environment combined effects, the interaction of VEGF 1451C > T and ... | BeFree | 25423914 | Detail |
0.018 | Malignant tumor of colon | This study showed that Lcn2-engineered MSCs (MSC-Lcn2) not only inhibited liver ... | BeFree | 25740061 | Detail |
0.018 | Malignant tumor of colon | Interleukin-1 Receptor Type 2 Acts with c-Fos to Enhance the Expression of Inter... | BeFree | 26209639 | Detail |
0.006 | Malignant neoplasm of endometrium | Alterations of angiogenic factors including angiotensin (AngII) or VEGF are obse... | BeFree | 25231075 | Detail |
0.006 | Malignant neoplasm of endometrium | We assessed the safety and activity of dovitinib, a potent tyrosine-kinase inhib... | BeFree | 25981814 | Detail |
<0.001 | Adenocarcinoma of prostate | NA | BeFree | Detail | |
0.002 | Rectal Carcinoma | Of the gene-environment combined effects, the interaction of VEGF 1451C > T and ... | BeFree | 25423914 | Detail |
<0.001 | Malignant neoplasm of skin | NA | BeFree | Detail | |
0.004 | Malignant neoplasm of thyroid | Transient Receptor Potential Canonical 1 (TRPC1) Channels as Regulators of Sphin... | BeFree | 25971967 | Detail |
0.005 | basal cell carcinoma | NA | LHGDN | Detail | |
<0.001 | Bronchioloalveolar Adenocarcinoma | NA | BeFree | Detail | |
0.007 | Noninfiltrating Intraductal Carcinoma | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Carcinoma, Ehrlich Tumor | NA | BeFree | Detail | |
<0.001 | Merkel cell carcinoma | NA | BeFree | Detail | |
0.003 | mucinous adenocarcinoma | NA | BeFree,LHGDN | Detail | |
0.149 | Non-small cell lung carcinoma | The effect of Lfcin-B on non-small cell lung cancer H460 cells is mediated by in... | BeFree,CTD_human,GAD | 24691828 | Detail |
0.149 | Non-small cell lung carcinoma | Our previous studies have found that HPV-16 oncoproteins promoted angiogenesis v... | BeFree,CTD_human,GAD | 25058399 | Detail |
0.149 | Non-small cell lung carcinoma | Retinoblastoma binding protein 2 (RBP2) promotes HIF-1α-VEGF-induced angiogenesi... | BeFree,CTD_human,GAD | 25162518 | Detail |
0.149 | Non-small cell lung carcinoma | EGF potentiation of VEGF production is cell density dependent in H292 EGFR wild ... | BeFree,CTD_human,GAD | 25272226 | Detail |
0.149 | Non-small cell lung carcinoma | Expressions of MUC1 and vascular endothelial growth factor mRNA in blood are bio... | BeFree,CTD_human,GAD | 25410981 | Detail |
0.149 | Non-small cell lung carcinoma | VEGF expression was significantly higher in NSCLC tissues than in normal lung ti... | BeFree,CTD_human,GAD | 25430449 | Detail |
0.149 | Non-small cell lung carcinoma | Through Western blot analysis, we identified that E-cadherin and vascular endoth... | BeFree,CTD_human,GAD | 25524578 | Detail |
0.149 | Non-small cell lung carcinoma | Mechanisms of and strategies for overcoming resistance to anti-vascular endothel... | BeFree,CTD_human,GAD | 25598052 | Detail |
0.149 | Non-small cell lung carcinoma | VEGF-A Expression Correlates with TP53 Mutations in Non-Small Cell Lung Cancer: ... | BeFree,CTD_human,GAD | 25672981 | Detail |
0.149 | Non-small cell lung carcinoma | These results suggest that low dose erlotinib-cisplatin combination exhibits its... | BeFree,CTD_human,GAD | 25748238 | Detail |
0.149 | Non-small cell lung carcinoma | Prognostic impact of elevation of vascular endothelial growth factor family expr... | BeFree,CTD_human,GAD | 25773840 | Detail |
0.149 | Non-small cell lung carcinoma | Vascular endothelial growth factor is an autocrine growth factor, signaling thro... | BeFree,CTD_human,GAD | 25889301 | Detail |
<0.001 | Carcinoma, Papillary | NA | BeFree | Detail | |
0.045 | renal cell carcinoma | We genotyped 70 genes involved in the pathogenesis of renal-cell carcinoma (incl... | BeFree,GAD,LHGDN | 24767687 | Detail |
0.045 | renal cell carcinoma | Carbonic anhydrase 9 expression increases with vascular endothelial growth facto... | BeFree,GAD,LHGDN | 24821582 | Detail |
0.045 | renal cell carcinoma | Predictive role of vascular endothelial growth factor polymorphisms in the survi... | BeFree,GAD,LHGDN | 25062489 | Detail |
0.045 | renal cell carcinoma | Several targeted therapies for advanced RCC have been approved and include sunit... | BeFree,GAD,LHGDN | 25365943 | Detail |
0.045 | renal cell carcinoma | The introduction of agents that inhibit tumor angiogenesis by targeting vascular... | BeFree,GAD,LHGDN | 25446042 | Detail |
0.045 | renal cell carcinoma | Advanced renal cell carcinoma (RCC) remains a largely incurable disease with a g... | BeFree,GAD,LHGDN | 25811348 | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
Expression of vascular endothelial growth factor (VEGF) in patients with oral squamous cell carcinom... | DisGeNET | Detail |
WISP-1 a novel angiogenic regulator of the CCN family promotes oral squamous cell carcinoma angiogen... | DisGeNET | Detail |
Increased TGFβ signaling and VEGF expression were observed in Col7 KD xenografts (n = 4) compared wi... | DisGeNET | Detail |
Gene expression of STAT3, NF-κB, TGFβ1, cyclin D1 and VEGFA was measured by quantitative real-time p... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Autoantibodies in dilated cardiomyopathy induce vascular endothelial growth factor expression in car... | DisGeNET | Detail |
The high comorbidity between cardiovascular disease and major depression disorder (MDD) prompted us ... | DisGeNET | Detail |
However, until now only a handful number of genetic variants were reported to be associated with eit... | DisGeNET | Detail |
In this study, production of elastase, interleukin (IL)-8 and vascular endothelial growth factor (VE... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Transplantation of BMSCs stably expressing mutant HIF1α significantly improved motor function, reduc... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Effects of VEGF suppression by small hairpin RNA interference combined with radiotherapy on the grow... | DisGeNET | Detail |
Molecular regulation of cervical cancer growth and invasion by VEGFa. | DisGeNET | Detail |
To investigate the effect of recombinant human p53 adenovirus injection combined with paclitaxel on ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Expressions of TGF-β1, TGF-β3, FGF-2, Sox9, Wnt-4, Foxc2, and VEGF-A mRNA were significantly higher ... | DisGeNET | Detail |
MicroRNA regulates vascular endothelial growth factor expression in chondrosarcoma cells. | DisGeNET | Detail |
CCL5 increased VEGF expression and also promoted chondrosarcoma conditional medium-mediated angiogen... | DisGeNET | Detail |
In this study, CCL5 increased VEGF expression and also promoted chondrosarcoma medium-mediated angio... | DisGeNET | Detail |
Basic fibroblast growth factor induces VEGF expression in chondrosarcoma cells and subsequently prom... | DisGeNET | Detail |
NA | DisGeNET | Detail |
We examined the growth-modulatory effects of different concentrations of heparin and VEGF on the cho... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We investigated whether vascular endothelial growth factor (VEGF) signaling via its receptor, VEGFR2... | DisGeNET | Detail |
Potential dual immunomodulatory role of VEGF in ulcerative colitis and colorectal carcinoma. | DisGeNET | Detail |
Our results showed that biglycan overexpression notably up-regulated the levels of VEGF in colon can... | DisGeNET | Detail |
Constant development of chemotherapy and more recently the introduction of VEGF- and epidermal growt... | DisGeNET | Detail |
Potential dual immunomodulatory role of VEGF in ulcerative colitis and colorectal carcinoma. | DisGeNET | Detail |
We analyzed VEGF (-2578C>A, -1498C>T, -1154G>A, -634C>G, +936C>T) and eNOS (+894G>T, -786T>C, VNTR (... | DisGeNET | Detail |
Association between EGF and VEGF functional polymorphisms and sporadic colorectal cancer in the Mala... | DisGeNET | Detail |
These results indicate that alternative splicing of an RNA binding protein can regulate isoform spec... | DisGeNET | Detail |
VEGF IHC positivity was significantly more common in patients with high expression levels of miR-376... | DisGeNET | Detail |
Interplay between 3'-UTR polymorphisms in the vascular endothelial growth factor (VEGF) gene and met... | DisGeNET | Detail |
The molecular targets of CRC include at least two important cell surface receptors: the epidermal gr... | DisGeNET | Detail |
We found that FIH-1 was able to inhibit HIF1α mediated transcription of GLUT1 and VEGF in CRC cells. | DisGeNET | Detail |
To characterize the population pharmacokinetics of bevacizumab, its binding properties to VEGF165 an... | DisGeNET | Detail |
Serum cytokine levels in patients with colorectal cancers according to tumor stages and VEGF gene po... | DisGeNET | Detail |
Furthermore, the expression level of excision repair cross-complementation group 1 mRNA in PPC speci... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Dysregulated miR-361-5p/VEGF axis in the plasma and endothelial progenitor cells of patients with co... | DisGeNET | Detail |
We aimed to investigate the correlation between the levels of circulating miR-214 and the expression... | DisGeNET | Detail |
Association between VEGF polymorphisms (936c/t, -460t/c and -634g/c) with haplotypes and coronary he... | DisGeNET | Detail |
Dysregulated miR-361-5p/VEGF axis in the plasma and endothelial progenitor cells of patients with co... | DisGeNET | Detail |
We aimed to investigate the correlation between the levels of circulating miR-214 and the expression... | DisGeNET | Detail |
Association between VEGF polymorphisms (936c/t, -460t/c and -634g/c) with haplotypes and coronary he... | DisGeNET | Detail |
NA | DisGeNET | Detail |
We retrieved 27 cases of 1-4-cm-sized adenoid cystic carcinomas (ACCs) arising from the PG (n = 12) ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Genes that were upregulated in VaD were MMP9 and VEGFA. | DisGeNET | Detail |
NA | DisGeNET | Detail |
Furthermore, our data also demonstrate that other factors than a diagnosis of depression influence t... | DisGeNET | Detail |
A higher VEGF concentration may play a potentially significant role in the pathogenesis of depressio... | DisGeNET | Detail |
Furthermore, our data also demonstrate that other factors than a diagnosis of depression influence t... | DisGeNET | Detail |
A higher VEGF concentration may play a potentially significant role in the pathogenesis of depressio... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
VEGF-A inhibition ameliorates podocyte apoptosis via repression of activating protein 1 in diabetes. | DisGeNET | Detail |
We have previously demonstrated that downregulation of miR-200b increases VEGF, mediating structural... | DisGeNET | Detail |
VEGF genetic polymorphisms may contribute to the risk of diabetic nephropathy in patients with diabe... | DisGeNET | Detail |
VEGF-A inhibition ameliorates podocyte apoptosis via repression of activating protein 1 in diabetes. | DisGeNET | Detail |
We have previously demonstrated that downregulation of miR-200b increases VEGF, mediating structural... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Placental vascular endothelial growth factor expression in pregnancies complicated by type 1 diabete... | DisGeNET | Detail |
Association of polymorphisms in the vascular endothelial growth factor gene and its serum levels wit... | DisGeNET | Detail |
In addition, VEGF serum levels were analyzed in 98 subjects with type 2 diabetes without CAD. | DisGeNET | Detail |
We have previously confirmed the associations of genetic variants in HHEX, CDKAL1, VEGFA and FTO wit... | DisGeNET | Detail |
Vascular endothelial growth factor A (VEGF) and its receptor KDR play central roles in angiogenesis ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Association of polymorphisms in the vascular endothelial growth factor gene and its serum levels wit... | DisGeNET | Detail |
To investigate how VEGF-634G/C and VEGF-460C/T SNPs are related to diabetic retinopathy (DR) in Han ... | DisGeNET | Detail |
Ocular anti-VEGF therapy is highly effective for treating a subset of patients with blinding eye dis... | DisGeNET | Detail |
We recently demonstrated that 12/15-lipoxygenase (LOX) derived metabolites, hydroxyeicosatetraenoic ... | DisGeNET | Detail |
Glucose-induced augmented vascular endothelial growth factor (VEGF) production is a key event in dia... | DisGeNET | Detail |
Moreover the study was intended to evaluate the role of VEGF gene single nucleotide polymorphisms (S... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Investigation of polymorphisms in pre-eclampsia related genes VEGF and IL1A. | DisGeNET | Detail |
Decreased placental miR-126 expression and vascular endothelial growth factor levels in patients wit... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Role of vascular endothelial growth factor polymorphisms (-2578C>A, -460 T>C, -1154G>A, +405G>C and ... | DisGeNET | Detail |
p27kip1 overexpression regulates VEGF expression, cell proliferation and apoptosis in cell culture f... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Role of +405C>G and +936C>T polymorphisms of the vascular endothelial growth factor gene and risk of... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
However, caution is required because the correlation was weak and there was a large overlap of FMISO... | DisGeNET | Detail |
Using the World Health Organization grade, histological subtype, and molecular variants (1p/19q code... | DisGeNET | Detail |
Interferon-β inhibits glioma angiogenesis through downregulation of vascular endothelial growth fact... | DisGeNET | Detail |
Although anti-VEGF therapy is widely used in high-grade gliomas, no predictor of response or toxicit... | DisGeNET | Detail |
We show here that a strong link exists among SRPK1, Akt, eIF4E, HIF-1, and VEGF activity that is fun... | DisGeNET | Detail |
We found that the glioma tissue was positive for A2B5 (Glial precursors ganglioside), GFAP (Glial fi... | DisGeNET | Detail |
By using gene silencing as an experimental approach we found that MMP14 knockdown decreases producti... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Cardiomyocyte-specific overexpression of the α1A-adrenergic receptors resulted in enhanced MEK-depen... | DisGeNET | Detail |
Cardiomyocyte-specific overexpression of the α1A-adrenergic receptors resulted in enhanced MEK-depen... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
i) Serum VEGF levels were higher in patients with progressive disease than those in patients with a ... | DisGeNET | Detail |
i) Serum VEGF levels were higher in patients with progressive disease than those in patients with a ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We performed immunohistochemical studies on 23 hemangioblastomas, 13 meningiomas and 4 hemangioperic... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Evaluating the SERCA2 and VEGF mRNAs as Potential Molecular Biomarkers of the Onset and Progression ... | DisGeNET | Detail |
Expression of VEGF in neonatal urinary obstruction: does expression of VEGF predict hydronephrosis? | DisGeNET | Detail |
Diagnostic values of vascular endothelial growth factor and epidermal growth factor receptor for ben... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The sEng, sFlt-1, and interleukin-6 were up-regulated, whereas the VEGF and PlGF were down-regulated... | DisGeNET | Detail |
Expression of FAM18B in primary human retinal microvascular endothelial cells (HRMECs) exposed to hy... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Increased angiogenic factors [vascular endothelial growth factor-A (VEGF-A) and angiopoietin-2 (Ang-... | DisGeNET | Detail |
Vascular endothelial growth factor (VEGF) is relevant for healthy pregnancy, and abnormalities in VE... | DisGeNET | Detail |
Vascular Endothelial Growth Factor A c.*237C>T polymorphism is associated with bevacizumab efficacy ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Given these results, here we analyzed the effect of HEXIM1 on the expression of HIF-1α and VEGF and ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Injection of only 10(4) hESC-derived SSEA-1(+) /MesP1(+) cells, or their progeny obtained after trea... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Collectively, we discovered a miR-361-5p/VEGF-dependent regulation that could help to develop new th... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Upregulated periostin promotes angiogenesis in keloids through activation of the ERK 1/2 and focal a... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In line, cell growth in leiomyosarcoma cell lines remained unchanged upon PTK787 treatment alone and... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Vascular endothelial growth factor A (VEGFA) gene polymorphisms have an impact on survival in a subg... | DisGeNET | Detail |
Clinical relevance of vascular endothelial growth factor type A (VEGFA) and VEGF receptor type 2 (VE... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
This was associated with concomitant attenuation of FoxM1 and its downstream genes, such as cyclin B... | DisGeNET | Detail |
Heparan sulfate D-glucosaminyl 3-O-sulfotransferase-3B1 (HS3ST3B1) promotes angiogenesis and prolife... | DisGeNET | Detail |
NA | DisGeNET | Detail |
In conclusion, CML in blast crisis had increased levels of CECs and VEGF gene expression, which may ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
These findings provide an animal model that reproduces the temporal and spatial specificities of PVL... | DisGeNET | Detail |
i) Serum VEGF levels were higher in patients with progressive disease than those in patients with a ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The effects of recombinant VEGF and its blockade on lung tumor cell proliferation and cell cycle wer... | DisGeNET | Detail |
Serum VEGF level in the active SLE group was significantly higher than that in the control group and... | DisGeNET | Detail |
We sought to determine the relevance of these findings to autoimmunity because elevated serum VEGF-A... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Lymphangiogenesis is actively contributed to lymphatic metastasis in gastric cancer (GC), and vascul... | DisGeNET | Detail |
NA | DisGeNET | Detail |
In summary, overexpression of VEGF in lymphoma tissue represents a promising potential prognostic fa... | DisGeNET | Detail |
NA | DisGeNET | Detail |
VEGF overexpression is a valuable prognostic factor for non-Hodgkin's lymphoma evidence from a syste... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Ocular anti-VEGF therapy is highly effective for treating a subset of patients with blinding eye dis... | DisGeNET | Detail |
Conbercept (KH902), a novel recombinant, soluble vascular endothelial growth factor (VEGF) receptor-... | DisGeNET | Detail |
The aqueous humor levels of IL-1β, IL-6, IL-8, MCP-1, IP-10, and VEGF were closely correlated with r... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In addition, ramucirumab, a monoclonal antibody targeting vascular endothelial growth factor recepto... | DisGeNET | Detail |
We performed a meta-analysis of individual patient data from six randomized phase III trials in colo... | DisGeNET | Detail |
Overexpression of different PFKFB in pancreatic and gastric cancer cells under hypoxic condition is ... | DisGeNET | Detail |
However, ramucirumab that targets VEGF receptor-2 prolonged overall survival in a large phase III cl... | DisGeNET | Detail |
Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF... | DisGeNET | Detail |
Lymphangiogenesis is actively contributed to lymphatic metastasis in gastric cancer (GC), and vascul... | DisGeNET | Detail |
miR-874 functions as a tumor suppressor by inhibiting angiogenesis through STAT3/VEGF-A pathway in g... | DisGeNET | Detail |
Gastric cancer-associated enhancement of von Willebrand factor is regulated by vascular endothelial ... | DisGeNET | Detail |
Pancreatic endoplasmic reticulum kinase activation promotes medulloblastoma cell migration and invas... | DisGeNET | Detail |
Previous studies indicate that fibroblast growth factors (b-FGF/FGF-2), an angiogenesis inducer beyo... | DisGeNET | Detail |
Induction of Vasculogenic Mimicry Overrides VEGF-A Silencing and Enriches Stem-like Cancer Cells in ... | DisGeNET | Detail |
Clinical and prognostic significance of survivin, AKT and VEGF in primary mucosal oral melanoma. | DisGeNET | Detail |
Simultaneous chemotherapy with vascular endothelial growth factor (VEGF) inhibition has not shown ad... | DisGeNET | Detail |
The expression of PRRs (Toll-like receptors and melanoma differentiation-associated gene 5) was indu... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Hypoxia inducible factor-1 is involved in growth factor, glucocorticoid and hypoxia mediated regulat... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We demonstrated increased expression of eIF4GI in myeloma cells and its attenuation upon VEGF inhibi... | DisGeNET | Detail |
Our data suggest that mTOR inhibition and silencing of VEGF expression is associated with synergisti... | DisGeNET | Detail |
By using global proteomic and transcriptomic profiling on melphalan sensitive and resistant RPMI8226... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The Wilms' tumor gene (WT1) and the vascular endothelial growth factor (VEGF) gene are highly expres... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Interaction between bone marrow stromal cells and neuroblastoma cells leads to a VEGFA-mediated oste... | DisGeNET | Detail |
Gain- and loss-of-function studies indicated that secretory ITLN1 facilitated the NDRG2 expression, ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Interplay between VEGF-A and cMET signaling in human vestibular schwannomas and schwann cells. | DisGeNET | Detail |
In conclusion, the results of the present study indicated that VEGF and pro-inflammatory cytokines m... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We investigated the efficacy of bevacizumab, an antibody against vascular endothelial growth factor ... | DisGeNET | Detail |
Arthritic synovial tissues from patients with rheumatoid arthritis (RA) or osteoarthritis (OA) were ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Expressions of TGF-β1, TGF-β3, FGF-2, Sox9, Wnt-4, Foxc2, and VEGF-A mRNA were significantly higher ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Autocrine VEGF/VEGFR1 signaling in a subpopulation of cells associates with aggressive osteosarcoma. | DisGeNET | Detail |
CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteo... | DisGeNET | Detail |
A key role of microRNA-29b in suppression of osteosarcoma cell proliferation and migration via modul... | DisGeNET | Detail |
In the present study, we show that galectin-3 silencing in cultured human osteosarcoma cells had dec... | DisGeNET | Detail |
Our findings suggest a cooperative relationship between miR-410 and VEGF in OS cell regulation. | DisGeNET | Detail |
Single nucleotide polymorphisms in VEGF gene are associated with an increased risk of osteosarcoma. | DisGeNET | Detail |
Effect of polymorphisms of vascular endothelial growth factor on prognosis in osteosarcoma patients. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the P... | DisGeNET | Detail |
These results suggested that VEGF could impact ovarian cancer's malignant progression by regulating ... | DisGeNET | Detail |
The median pretreatment serum VEGF and survivin levels in patients with serous ovarian carcinoma wer... | DisGeNET | Detail |
Our data reveal a new potential pathway in which VEGF promotes the invasion of ovarian cancer cells,... | DisGeNET | Detail |
IKKβ Regulates VEGF Expression and Is a Potential Therapeutic Target for Ovarian Cancer as an Antian... | DisGeNET | Detail |
To assess the angiogenic properties of fibulin-4, vascular endothelial growth factor (VEGF) expressi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The pancreatic tumors of the mice injected with nanoparticles loaded with EPAS1 siRNA were significa... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The expression profile of Dopamine D2 receptor, MGMT and VEGF in different histological subtypes of ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In malignant pleural effusion caused by cancers of different origin, the vascular endothelial growth... | DisGeNET | Detail |
VEGF and EGFR play important roles in the formation of pleural effusion. | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our findings suggest that the VEGF +405G/C polymorphism may constitute an inheritable risk factor fo... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Association study of vascular endothelial growth factor gene polymorphisms with ectopic pregnancy in... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Identification of modifier genes, such as vascular endothelial growth factor A, has further contribu... | DisGeNET | Detail |
Psoriasis (Ps) is an autoimmune disease characterized by keratinocyte hyperproliferation and chronic... | DisGeNET | Detail |
Therefore, we proposed that targeting VEGF/VEGFRs could lead to new treatments for psoriasis. | DisGeNET | Detail |
A TACE inhibitor abrogated EGFR ligand-dependent keratinocyte proliferation and VEGF production in v... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overexpression of angiogenic factors (activation of VEGF through HIF-1A) may predispose to chronic c... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Transfection of both genes had greater inhibitory effects on RB development and resulted in lower le... | DisGeNET | Detail |
Despite evidence that hypoxia inducible factor (HIF)-1α -VEGF axis is associated with the pathogenes... | DisGeNET | Detail |
Our evidence also suggests that the VEGF pathway and downstream NFKB signaling may explain the compl... | DisGeNET | Detail |
Vascular endothelial growth factor (VEGF) is a key regulator of angiogenesis and thus contributes to... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
These findings were in line with previous data on the role of HIF-1A/VEGF/ING-4 axis in the pathogen... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Vascular endothelial growth factor A polymorphism and risk of Kaposi's sarcoma herpesvirus viremia i... | DisGeNET | Detail |
Repression of Bcr correlated with the activation of a protein previously shown to cause KS-like lesi... | DisGeNET | Detail |
Association study of VEGFA polymorphisms with schizophrenia in Han Chinese population. | DisGeNET | Detail |
NA | DisGeNET | Detail |
After sorting, we showed: i. an increased production of vascular endothelial growth factor A (VEGF-A... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In conclusion, IL-8 stimulates VEGF production in hBM-MSCs in part via the PI3K/Akt and MAPK/ERK sig... | DisGeNET | Detail |
Transplantation of BMSCs stably expressing mutant HIF1α significantly improved motor function, reduc... | DisGeNET | Detail |
Our findings have implications for the use of cancer therapies that target VEGF or IL6 and for under... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The rates of positive immunostaining for COX-2, MMP-9 and VEGF in PTC tumours were significantly hig... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Indeed, we demonstrate in two multiplex consanguineous families that we are able to map TA to region... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Vascular endothelial growth factor A gene expression level is higher in patients with major depressi... | DisGeNET | Detail |
To investigate microvessel density (MVD), vascular endothelial growth factor (VEGF), endothelial nit... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Calcitonin gene-related peptide and vascular endothelial growth factor are expressed in lesional but... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Increased TGFβ signaling and VEGF expression were observed in Col7 KD xenografts (n = 4) compared wi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Consequently, genetic or pharmacologic inhibition of integrin αvβ3 decreased VEGF production and ind... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Targeting VEGF and interleukin-6 for controlling malignant effusion of primary effusion lymphoma. | DisGeNET | Detail |
The detection of LUNX mRNA and vascular endothelial growth factor mRNA in pleural fluid may be a com... | DisGeNET | Detail |
VEGF differed significantly in benign and malignant pleural effusions, which contributed to differen... | DisGeNET | Detail |
Polymorphisms of VEGF and VEGF receptors are associated with the occurrence of ovarian hyperstimulat... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Subconjunctival bevacizumab helps to regress CNV due to a decrease in corneal VEGF levels and might ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
High expression of VEGF-A was observed in 81% (183/224) of tumors and 5.1% (2/39) of chronic cholecy... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
It seems therefore that serum VEGF level may be a reliable biomarker and may be a potential target f... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Cardiomyocyte-specific overexpression of the α1A-adrenergic receptors resulted in enhanced MEK-depen... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Role of +405C>G and +936C>T polymorphisms of the vascular endothelial growth factor gene and risk of... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Administration of BMP9 reversed established PAH in these mice, as well as in two other experimental ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Serum VEGF levels were significantly higher in oral cancer patients (p<0.0001) as compared to normal... | DisGeNET | Detail |
VEGFA isoforms play a vital role in oral cancer progression. | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our results indicate that VEGF-A is highly expressed in GBC and correlates with poor prognosis, sugg... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Bone metastases (BMs) are associated with poor outcome in metastatic clear-cell renal carcinoma (m-c... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Increased expression of CGRP and VEGF in lesional, but not uninvolved, skin indicates that these pot... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Recently, proangiogenic factors hypoxia-inducible factor-1 alpha (HIF-1α) and vascular endothelial g... | DisGeNET | Detail |
NA | DisGeNET | Detail |
In this study, the functional variants in genes involved in the hypoxia signaling pathway, hypoxia-i... | DisGeNET | Detail |
The haplotype analysis suggested that the TAA (VEGF -460/-1154/-2578) and CAA haplotypes could signi... | DisGeNET | Detail |
We retrieved 27 cases of 1-4-cm-sized adenoid cystic carcinomas (ACCs) arising from the PG (n = 12) ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Regarding the significant role of vascular endothelial growth factor (VEGF) in angiogenesis and tumo... | DisGeNET | Detail |
IR also triggers cellular secretion of vascular endothelial growth factor, transforming growth facto... | DisGeNET | Detail |
No significant risk for developing tumor progression was associated with Ki-67, p53, Bax, Bcl-2, VEG... | DisGeNET | Detail |
Recent evidence indicates that LKB1 alterations contribute to cancer progression and metastasis by m... | DisGeNET | Detail |
Vascular endothelial growth factor-C (VEGF-C) plays an important role during cancer progression and ... | DisGeNET | Detail |
VEGF-A is the most established angiogenic factor involved in the angiogenic-regulated tumor progress... | DisGeNET | Detail |
Our results support that osteopontin regulates ICAM-1 and VEGFA expression mainly in triple-negative... | DisGeNET | Detail |
Expression of VEGF in neonatal urinary obstruction: does expression of VEGF predict hydronephrosis? | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Given the preclinical evidence implicating vascular endothelial growth factor (VEGF) signaling in th... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The molecular and cellular functions predicted for these CCA specific genes according to the Gene On... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Collectively, our data provide evidence that propranolol may regress infantile hemangiomas by suppre... | DisGeNET | Detail |
The VHL-HIF-1 regulated genes VEGF and CAIX are expressed in hemangioblastomas but significant HIG-2... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Neuroendocrine cancer cell lines are used to investigate therapeutic targets in neuroendocrine tumor... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
It seems therefore that serum VEGF level may be a reliable biomarker and may be a potential target f... | DisGeNET | Detail |
VEGFA isoforms play a vital role in oral cancer progression. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overall, these results reveal a pathogenic mechanism in NP-C neurons where defective SphK activity i... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Immunohistochemical expression of vascular endothelial growth factor A in advanced gallbladder carci... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our results demonstrated that DAPK1 gene over-expression can suppress the proliferation, migration, ... | DisGeNET | Detail |
VEGF-A is the most specific and prominent angiogenic factor among all family members and VEGFR-2 is ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Clinical significance of vascular endothelial growth factor and vascular endothelial growth factor r... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Immunohistochemical levels of cyclo-oxygenase-2, matrix metalloproteinase-9 and vascular endothelial... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Captopril and losartan also suppressed vascular endothelial growth factor-A expression in LLC cells ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
i) Serum VEGF levels were higher in patients with progressive disease than those in patients with a ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Mechanical stimuli, like mechanical stretch in respiratory and circulatory systems, results in an el... | DisGeNET | Detail |
Conbercept (KH902), a novel recombinant, soluble vascular endothelial growth factor (VEGF) receptor-... | DisGeNET | Detail |
The aqueous humor levels of IL-1β, IL-6, IL-8, MCP-1, IP-10, and VEGF were closely correlated with r... | DisGeNET | Detail |
Ocular anti-VEGF therapy is highly effective for treating a subset of patients with blinding eye dis... | DisGeNET | Detail |
Differential expression of vascular endothelial growth factor-a isoforms in neovascular age-related ... | DisGeNET | Detail |
Pharmacogenomics of response to anti-VEGF therapy in exudative age-related macular degeneration. | DisGeNET | Detail |
Here, we engineered a Two-in-One VEGF/angiopoietin 2 antibody with dual action Fab (DAF) as a potent... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Based on our data comparing human IL-18 to current anti-VEGF-based therapy, clinical deployment of I... | DisGeNET | Detail |
Ocular anti-VEGF therapy is highly effective for treating a subset of patients with blinding eye dis... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Vascular endothelial growth factor-A is associated with chronic mountain sickness in the Andean popu... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Association of VEGF-A splice variant mRNA expression with outcome in bevacizumab-treated patients wi... | DisGeNET | Detail |
Of the 102 stage I NSCLC specimens analyzed, high RBP2 protein expression is closely associated with... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
MEDLINE/PubMed and the Cochrane Library were searched for randomised phase III trials that compared ... | DisGeNET | Detail |
The aim of this prospective, noninterventional, observational study was to assess efficacy and safet... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Sorafenib (SOR), a vascular endothelial growth factor receptor (VEGFR) inhibitor, is in wide clinica... | DisGeNET | Detail |
Genetic variants of EGF and VEGF predict prognosis of patients with advanced esophageal squamous cel... | DisGeNET | Detail |
RhoC, vascular endothelial growth factor and microvascular density in esophageal squamous cell carci... | DisGeNET | Detail |
Discovery and validation of vascular endothelial growth factor (VEGF) pathway polymorphisms in esoph... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Given that the tumor-promoting inflammation has been previously established in squamous cell carcino... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Dual antiangiogenic inhibition: a phase I dose escalation and expansion trial targeting VEGF-A and V... | DisGeNET | Detail |
Specific variations of VEGF genes have been demonstrated to be genetic determinants for susceptibili... | DisGeNET | Detail |
The failure of standard treatment for patients diagnosed with glioblastoma (GBM) coupled with the hi... | DisGeNET | Detail |
Patients with refractory solid tumors were enrolled in a modified 3 + 3 Phase I dose escalation stud... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Significance of the expression of integrin β1, VEGF and MVD in hypopharyngeal squamous cell carcinom... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Effects of VEGF suppression by small hairpin RNA interference combined with radiotherapy on the grow... | DisGeNET | Detail |
Molecular regulation of cervical cancer growth and invasion by VEGFa. | DisGeNET | Detail |
To investigate the effect of recombinant human p53 adenovirus injection combined with paclitaxel on ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Importantly, the therapeutic mechanism of antitumor effect mediated by RdB/FP3 is associated with pr... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Anti-VEGF therapy may be a candidate for PPC, while cisplatin also remains a viable option. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Within the 1p/19q-codeleted AO, the contrast enhancement was associated with larger tumor volumes (P... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Intravitreal anti-VEGF therapy if initiated timely is effective in SFD patients with CNV. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Role of the VEGF 936 gene polymorphism and VEGF-A levels in the late-term arteriovenous fistula thro... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Sorafenib (SOR), a vascular endothelial growth factor receptor (VEGFR) inhibitor, is in wide clinica... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In this study, we reported for the first time that Celastrol could induce HIF-1α protein accumulatio... | DisGeNET | Detail |
VEGF-A is the most specific and prominent angiogenic factor among all family members and VEGFR-2 is ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
VEGF levels were measured in serum by immunoassay and independent determinants of the serum VEGF lev... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Sevoflurane attenuate hypoxia-induced VEGF level in tongue squamous cell carcinoma cell by upregulat... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Although Helicobacter pylori have been known to induce vascular endothelial growth factor (VEGF) pro... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Associations of nm23H1, VEGF-C, and VEGF-3 receptor in human prostate cancer. | DisGeNET | Detail |
Vasoactive intestinal peptide (VIP) exerts similar effects in prostate cancer models involving incre... | DisGeNET | Detail |
Adiponectin inhibits VEGF-A in prostate cancer cells. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Follistatin, angiopoietin-2, and VEGF may have potential as biochemical markers for the assessment o... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Alterations of angiogenic factors including angiotensin (AngII) or VEGF are observed in EC. | DisGeNET | Detail |
We assessed the safety and activity of dovitinib, a potent tyrosine-kinase inhibitor of fibroblast g... | DisGeNET | Detail |
Our experimental results suggest that HCS has some anti-metastasis potential to suppress the growth ... | DisGeNET | Detail |
This study showed that Lcn2-engineered MSCs (MSC-Lcn2) not only inhibited liver metastasis of colon ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Intestinal vascular endothelial growth factor is decreased in necrotizing enterocolitis. | DisGeNET | Detail |
NA | DisGeNET | Detail |
Vascular endothelial growth factor genotypes and haplotypes contribute to the susceptibility of obst... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Therefore, we studied peritoneal expression of CCN2, as well as TGFβ1 and VEGF, in different stages ... | DisGeNET | Detail |
Interplay between 3'-UTR polymorphisms in the vascular endothelial growth factor (VEGF) gene and met... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Role of +405C>G and +936C>T polymorphisms of the vascular endothelial growth factor gene and risk of... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Transient Receptor Potential Canonical 1 (TRPC1) Channels as Regulators of Sphingolipid and VEGF Rec... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Correlation between ¹⁸F-fluoromisonidazole PET and expression of HIF-1α and VEGF in newly diagnosed ... | DisGeNET | Detail |
In this study, we demonstrate the feasibility of combining adenovirus-mediated soluble VEGF receptor... | DisGeNET | Detail |
One of the important roles of IFN-β for malignant glioma growth inhibition was anti-angiogenesis by ... | DisGeNET | Detail |
The vascular endothelial growth factor (VEGF)/VEGF receptor (VEGFR) signaling cascade plays a critic... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Production of IL-8, VEGF and Elastase by Circulating and Intraplaque Neutrophils in Patients with Ca... | DisGeNET | Detail |
Autocrine VEGF/VEGFR1 signaling in a subpopulation of cells associates with aggressive osteosarcoma. | DisGeNET | Detail |
CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteo... | DisGeNET | Detail |
A key role of microRNA-29b in suppression of osteosarcoma cell proliferation and migration via modul... | DisGeNET | Detail |
In the present study, we show that galectin-3 silencing in cultured human osteosarcoma cells had dec... | DisGeNET | Detail |
Our findings suggest a cooperative relationship between miR-410 and VEGF in OS cell regulation. | DisGeNET | Detail |
Single nucleotide polymorphisms in VEGF gene are associated with an increased risk of osteosarcoma. | DisGeNET | Detail |
Effect of polymorphisms of vascular endothelial growth factor on prognosis in osteosarcoma patients. | DisGeNET | Detail |
The present study aims to clarify the changes in conbercept levels, VEGF, and intraocular pressure (... | DisGeNET | Detail |
The concentrations of PPARγ and vascular endothelial growth factor (VEGF) in the aqueous humor and v... | DisGeNET | Detail |
Compared with diabetic patients without ME, diabetic patients with ME had significantly higher conce... | DisGeNET | Detail |
The vascular endothelial growth factor A (VEGF-A) is a potent proangiogenic agent involved in the ca... | DisGeNET | Detail |
It was concluded that BZG-4000 has the potential to inhibit the tumorigenesis of hepatocellular carc... | DisGeNET | Detail |
Kinase insert domain receptor (KDR) is the principal receptor that promotes the proangiogenic action... | DisGeNET | Detail |
+936C>T polymorphism of vascular endothelial growth factor (VEGF) is one of the most investigated po... | DisGeNET | Detail |
Structure-fluctuation-function relationships of seven pro-angiogenic isoforms of VEGFA, important me... | DisGeNET | Detail |
The vascular endothelial growth factor family has been implicated in tumorigenesis and metastasis. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Associations of nm23H1, VEGF-C, and VEGF-3 receptor in human prostate cancer. | DisGeNET | Detail |
Vasoactive intestinal peptide (VIP) exerts similar effects in prostate cancer models involving incre... | DisGeNET | Detail |
Adiponectin inhibits VEGF-A in prostate cancer cells. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Vascular endothelial growth factor (VEGF) polymorphism and increased risk of epithelial ovarian canc... | DisGeNET | Detail |
Serial sections of paraffin embedded ovarian tissues from 70 patients diagnosed with epithelial ovar... | DisGeNET | Detail |
The median pretreatment serum VEGF and survivin levels in patients with serous ovarian carcinoma wer... | DisGeNET | Detail |
To assess the angiogenic properties of fibulin-4, vascular endothelial growth factor (VEGF) expressi... | DisGeNET | Detail |
Blood levels of MUC1 and VEGF mRNA at B0 and at B4w were significantly higher in patients with progr... | DisGeNET | Detail |
i) Serum VEGF levels were higher in patients with progressive disease than those in patients with a ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The VEGF positive rate in patients at a later clinical stage was higher than that of the patients at... | DisGeNET | Detail |
VEGF expression was significantly higher in hypopharyngeal squamous cell carcinoma tissues (74.00%) ... | DisGeNET | Detail |
The present study aimed to investigate the expression patterns of HGF‑α and c‑Met and their associat... | DisGeNET | Detail |
The positive expression of VEGF protein in cancer tissues with lymph node metastasis was significant... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Biglycan up-regulated vascular endothelial growth factor (VEGF) expression and promoted angiogenesis... | DisGeNET | Detail |
Of the gene-environment combined effects, the interaction of VEGF 1451C > T and MetS contributed to ... | DisGeNET | Detail |
This study showed that Lcn2-engineered MSCs (MSC-Lcn2) not only inhibited liver metastasis of colon ... | DisGeNET | Detail |
Interleukin-1 Receptor Type 2 Acts with c-Fos to Enhance the Expression of Interleukin-6 and Vascula... | DisGeNET | Detail |
In addition, ramucirumab, a monoclonal antibody targeting vascular endothelial growth factor recepto... | DisGeNET | Detail |
We performed a meta-analysis of individual patient data from six randomized phase III trials in colo... | DisGeNET | Detail |
Overexpression of different PFKFB in pancreatic and gastric cancer cells under hypoxic condition is ... | DisGeNET | Detail |
However, ramucirumab that targets VEGF receptor-2 prolonged overall survival in a large phase III cl... | DisGeNET | Detail |
Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF... | DisGeNET | Detail |
Lymphangiogenesis is actively contributed to lymphatic metastasis in gastric cancer (GC), and vascul... | DisGeNET | Detail |
miR-874 functions as a tumor suppressor by inhibiting angiogenesis through STAT3/VEGF-A pathway in g... | DisGeNET | Detail |
SUZ12 siRNA inhibits the invasion of gastric carcinoma cells and the expression of VEGF, MMP-2 and M... | DisGeNET | Detail |
Gastric cancer-associated enhancement of von Willebrand factor is regulated by vascular endothelial ... | DisGeNET | Detail |
SUZ12 siRNA inhibits the invasion of gastric carcinoma cells and the expression of VEGF, MMP-2 and M... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Interaction between bone marrow stromal cells and neuroblastoma cells leads to a VEGFA-mediated oste... | DisGeNET | Detail |
Gain- and loss-of-function studies indicated that secretory ITLN1 facilitated the NDRG2 expression, ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
HIF-1alpha and vascular endothelial growth factor (VEGF) mRNA and protein expression were also evalu... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Maternal plasma VEGF levels in early pregnancy were positively associated with systolic blood pressu... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The pathological diagnosis of malignant schwannoma indicated that the p53 expression was strongly po... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Reduced vascular endothelial growth factor and capillary density in the occipital cortex in dementia... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In addition, miR-126 overexpression significantly upregulated VEGF expression in BeWo cells, whereas... | DisGeNET | Detail |
In this review, we focus on the main genes that are epigenetically modified during the atherogenic p... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Leucocyte infiltration with vascular leakage and expression of the potent vasoactive agents' calcito... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In this way, the anti-VEGF antibody bevacizumab in combination with chemotherapy has provided import... | DisGeNET | Detail |
The VEGF- (bevacizumab) and EGFR- (cetuximab and panitumumab) targeting monoclonal antibodies have b... | DisGeNET | Detail |
Vascular Endothelial Growth Factor A c.*237C>T polymorphism is associated with bevacizumab efficacy ... | DisGeNET | Detail |
Second-line treatment with chemotherapy and anti-epidermal growth factor receptor or anti-vascular e... | DisGeNET | Detail |
Ninety-six somatic mutations in key oncogenic drivers of mCRC and 133 common single-nucleotide polym... | DisGeNET | Detail |
NA | DisGeNET | Detail |
We sought to determine the relevance of these findings to autoimmunity because elevated serum VEGF-A... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the P... | DisGeNET | Detail |
These results suggested that VEGF could impact ovarian cancer's malignant progression by regulating ... | DisGeNET | Detail |
Our data reveal a new potential pathway in which VEGF promotes the invasion of ovarian cancer cells,... | DisGeNET | Detail |
IKKβ Regulates VEGF Expression and Is a Potential Therapeutic Target for Ovarian Cancer as an Antian... | DisGeNET | Detail |
NA | DisGeNET | Detail |
PC7 (PCSK7) and furin siRNAs upregulated HIF-1α protein under normoxic condition to a level similar ... | DisGeNET | Detail |
We found that garcinol inhibited the viability of a panel of diverse HNSCC cell lines, enhanced the ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Vascular endothelial growth factor A gene expression level is higher in patients with major depressi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
VEGF-A165 and VEGF-A189 are significantly higher in CNV than in control choroids, the opposite is fo... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Previous research has indicated that modified VEGF-VEGFR signaling pathway has an impact on the deve... | DisGeNET | Detail |
Targeting VEGF and interleukin-6 for controlling malignant effusion of primary effusion lymphoma. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In the in vitro experiments, LPS preconditioning of ASCs enhanced the mRNA expression levels of inte... | DisGeNET | Detail |
NA | DisGeNET | Detail |
C936T polymorphism of the VEGF gene in relation to the risk and the clinical and biological characte... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
VEGF, PDGF, FGF and their receptors are expressed at high levels and correlate with poor prognosis i... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Targeting vascular endothelial growth factor (VEGF) pathway in iodine-refractory differentiated thyr... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The ShcA adaptor activates AKT signaling to potentiate breast tumor angiogenesis by stimulating VEGF... | DisGeNET | Detail |
OPN also regulates hypoxia-inducible factor-1α-dependent VEGF expression leading to breast tumor gro... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
These findings establish ShcA as a biological bridge that links AKT activation downstream of RTKs to... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Hypoxia stimulates several pathways that are critical to cancer cell growth and survival, including ... | DisGeNET | Detail |
Furthermore, the effects of VEGFa-induced activation of mTor signaling cascades appeared to promote ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In conclusion, MTA1 is a potent angiogenic molecule and cross talk between VEGF and MTA1 protein reg... | DisGeNET | Detail |
To investigate the inhibitory effect of Coptidis rhizome aqueous extract (CRAE) on vascular endothel... | DisGeNET | Detail |
In addition to interrogating the effect of gene knockdown in endothelial cells, we utilized lentivir... | DisGeNET | Detail |
MMP9 also enhances PKD2-mediated tumor angiogenesis releasing extracellular matrix-bound VEGF-A. | DisGeNET | Detail |
Collectively, we discovered a miR-361-5p/VEGF-dependent regulation that could help to develop new th... | DisGeNET | Detail |
Western Blot and immunohistochemistry staining showed that Ad5/F35-XAF1 treatment suppressed express... | DisGeNET | Detail |
Of the 102 stage I NSCLC specimens analyzed, high RBP2 protein expression is closely associated with... | DisGeNET | Detail |
Survivin expression promotes VEGF-induced tumor angiogenesis via PI3K/Akt enhanced β-catenin/Tcf-Lef... | DisGeNET | Detail |
CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteo... | DisGeNET | Detail |
TARAP was found to suppress the expression of vascular endothelial growth factor (VEGF) A and VEGF r... | DisGeNET | Detail |
The vascular endothelial growth factor (VEGF)/VEGF receptor (VEGFR) signaling cascade plays a critic... | DisGeNET | Detail |
Taken together, our results indicated that biglycan up-regulated VEGF expression in colon cancer cel... | DisGeNET | Detail |
Moreover, F2 suppressed vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMP... | DisGeNET | Detail |
The major mediator of tumor angiogenesis is VEGF-A, frequently referred to as VEGF, which activates ... | DisGeNET | Detail |
It mediates downstream hypoxia-inducible factor 1α accumulation in the nucleus, and then activates t... | DisGeNET | Detail |
RhoC protein may upregulate VEGF expression, thereby promoting tumor angiogenesis. | DisGeNET | Detail |
Evidence is accumulating that activation of the pancreatic endoplasmic reticulum kinase (PERK) in re... | DisGeNET | Detail |
Consistent with these data, RdB/FP3 was shown to greatly decrease VEGF expression level and vessel d... | DisGeNET | Detail |
Antiangiogenic VEGF-Ax: A New Participant in Tumor Angiogenesis. | DisGeNET | Detail |
They can modulate pro-angiogenic signals induced by vascular endothelial growth factor (VEGF) and an... | DisGeNET | Detail |
Vascular endothelial growth factor (VEGF) was considered as a critical growth factor for tumor expan... | DisGeNET | Detail |
Growth-stimulating effects of ERβ may be due in part to downstream actions that promote VEGF, amphir... | DisGeNET | Detail |
Gene transfection and silencing, and antitumor effect of the At-Lp loaded with VEGF siRNA were evalu... | DisGeNET | Detail |
Consequently, genetic or pharmacologic inhibition of integrin αvβ3 decreased VEGF production and ind... | DisGeNET | Detail |
Finally, we demonstrate for the first time that curcumin analogues EF31 and UBS109 induce the downre... | DisGeNET | Detail |
In a xenograft model, the treatment of IMD-0354 significantly inhibited peritoneal dissemination wit... | DisGeNET | Detail |
Constant development of chemotherapy and more recently the introduction of VEGF- and epidermal growt... | DisGeNET | Detail |
We analyzed VEGF (-2578C>A, -1498C>T, -1154G>A, -634C>G, +936C>T) and eNOS (+894G>T, -786T>C, VNTR (... | DisGeNET | Detail |
Association between EGF and VEGF functional polymorphisms and sporadic colorectal cancer in the Mala... | DisGeNET | Detail |
These results indicate that alternative splicing of an RNA binding protein can regulate isoform spec... | DisGeNET | Detail |
VEGF IHC positivity was significantly more common in patients with high expression levels of miR-376... | DisGeNET | Detail |
Interplay between 3'-UTR polymorphisms in the vascular endothelial growth factor (VEGF) gene and met... | DisGeNET | Detail |
The molecular targets of CRC include at least two important cell surface receptors: the epidermal gr... | DisGeNET | Detail |
We found that FIH-1 was able to inhibit HIF1α mediated transcription of GLUT1 and VEGF in CRC cells. | DisGeNET | Detail |
To characterize the population pharmacokinetics of bevacizumab, its binding properties to VEGF165 an... | DisGeNET | Detail |
Serum cytokine levels in patients with colorectal cancers according to tumor stages and VEGF gene po... | DisGeNET | Detail |
Furthermore, the expression level of excision repair cross-complementation group 1 mRNA in PPC speci... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In a PEL xenograft mouse model that showed profuse ascites, bevacizumab suppressed ascites formation... | DisGeNET | Detail |
Levels of lipopolysaccharide-binding protein in plasma and highly sensitive C-reactive protein, tumo... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
AAVrh.10BevMab, an AAVrh.10-based vector coding for bevacizumab (Avastin), an anti-human vascular en... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Targeting angiogenesis by inhibition of vascular endothelial growth factor (VEGF) receptor tyrosine ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In univariate analysis, a significantly increased risk for development of AAA without coexisting PAD... | DisGeNET | Detail |
These findings demonstrate that PKR mediates angiogenesis through a VEGF pathway, which may form the... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Hypoxia inducible factor-1 is involved in growth factor, glucocorticoid and hypoxia mediated regulat... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Alterations of angiogenic factors including angiotensin (AngII) or VEGF are observed in EC. | DisGeNET | Detail |
We assessed the safety and activity of dovitinib, a potent tyrosine-kinase inhibitor of fibroblast g... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Dysregulated miR-361-5p/VEGF axis in the plasma and endothelial progenitor cells of patients with co... | DisGeNET | Detail |
In addition, VEGF serum levels were analyzed in 98 subjects with type 2 diabetes without CAD. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Gene expression of STAT3, NF-κB, TGFβ1, cyclin D1 and VEGFA was measured by quantitative real-time p... | DisGeNET | Detail |
Suppression of vascular endothelial growth factor via inactivation of eukaryotic elongation factor 2... | DisGeNET | Detail |
Silencing alpha-fetoprotein inhibits VEGF and MMP-2/9 production in human hepatocellular carcinoma c... | DisGeNET | Detail |
It was concluded that BZG-4000 has the potential to inhibit the tumorigenesis of hepatocellular carc... | DisGeNET | Detail |
Expression characteristics of KAI1 and vascular endothelial growth factor and their diagnostic value... | DisGeNET | Detail |
Kinase insert domain receptor (KDR) is the principal receptor that promotes the proangiogenic action... | DisGeNET | Detail |
Tube formation of HUVECs was assessed with an ECMatrix gel system, and mRNA and protein expression o... | DisGeNET | Detail |
The goal of this study was to determine the interaction between CD105 and VEGF in HCC, using HCC tis... | DisGeNET | Detail |
Our results showed that conditional medium from co-culture of HCC/HSCs induced VEGF secretions and s... | DisGeNET | Detail |
Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth fa... | DisGeNET | Detail |
In conclusion, the present study suggests that hypoxia-induced PDGF-BB secretion by HCC cells stimul... | DisGeNET | Detail |
Polymorphisms of vascular endothelial growth factor on prognosis in hepatocellular carcinoma patient... | DisGeNET | Detail |
γ-H2AX knockdown was able to effectively inhibit VEGF expression in vitro and tumorigenicity and ang... | DisGeNET | Detail |
After hepatoma, cells were transfected with shRNA, GPC-3 expression or proliferation was inhibited w... | DisGeNET | Detail |
microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellu... | DisGeNET | Detail |
This study suggested that chronic moderate alcohol consumption may promote the progression and metas... | DisGeNET | Detail |
The aim of this study was to investigate the effects of the vascular endothelial growth factor (VEGF... | DisGeNET | Detail |
VEGF in patients with advanced hepatocellular carcinoma receiving intra-arterial chemotherapy. | DisGeNET | Detail |
Lysyl Oxidase Is Predictive of Unfavorable Outcomes and Essential for Regulation of Vascular Endothe... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
HIF-1alpha and VEGF expression increased in the nasal mucosa of patients with AR, showing the role o... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Compared with vector-alone control cells, BLU stable transfectants, derived from poorly-differentiat... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Pre-clinical studies and Phase I clinical trials using VEGF and fibroblast growth factor (FGF) demon... | DisGeNET | Detail |
Administration of BMP9 reversed established PAH in these mice, as well as in two other experimental ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Blood levels of MUC1 and VEGF mRNA at B0 and at B4w were significantly higher in patients with progr... | DisGeNET | Detail |
i) Serum VEGF levels were higher in patients with progressive disease than those in patients with a ... | DisGeNET | Detail |
Treatment of TNBC cell lines with dutasteride was associated with a dose-dependent decrease in cell ... | DisGeNET | Detail |
We investigated the therapeutic impact of a vaccinia virus (VACV) GLV-1h164 (derived from its parent... | DisGeNET | Detail |
We have previously shown that vascular endothelial growth factor (VEGF) expression in triple negativ... | DisGeNET | Detail |
Transforming growth factor-β, insulin-like growth factor I/insulin-like growth factor I receptor and... | DisGeNET | Detail |
VEGF-A, IGF-I and IGF-IR play an important role in the development and progression of TNBC compared ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our results support that osteopontin regulates ICAM-1 and VEGFA expression mainly in triple-negative... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Administration of BMP9 reversed established PAH in these mice, as well as in two other experimental ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
VEGF neutralizing aerosol therapy in primary pulmonary adenocarcinoma with K-ras activating-mutation... | DisGeNET | Detail |
Especially, VEGFA over-expression was an independent prognostic factor in adenocarcinoma (ADC) (HR=1... | DisGeNET | Detail |
NA | DisGeNET | Detail |
After stratifying by tumor molecular subtype, SNP associations observed for colon cancer were: VEGFA... | DisGeNET | Detail |
NA | DisGeNET | Detail |
After stratifying by tumor molecular subtype, SNP associations observed for colon cancer were: VEGFA... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
After stratifying by tumor molecular subtype, SNP associations observed for colon cancer were: VEGFA... | DisGeNET | Detail |
The excess vascular endothelial growth factor (VEGF) produced in the Alzheimer's disease (AD) brain ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
VEGFR2-mediated vascular dilation as a mechanism of VEGF-induced anemia and bone marrow cell mobiliz... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
This study identifies polymorphisms in the HIF1A and VEGF genes as potential genetic markers that in... | DisGeNET | Detail |
NA | DisGeNET | Detail |
This study identifies polymorphisms in the HIF1A and VEGF genes as potential genetic markers that in... | DisGeNET | Detail |
The role of miR-26a in atherosclerosis is mediated by its target EphA2 via a mechanism involving the... | DisGeNET | Detail |
NA | DisGeNET | Detail |
There is an increased risk of AV fistula thrombosis in individuals carrying the VEGF-936C/C genotype... | DisGeNET | Detail |
The outflow vein was removed three days following the creation of the AVF and gene expression analys... | DisGeNET | Detail |
Cultured AVMECs expressed higher angiogenic factors (VEGF, MMP-2) than the controlled BECs, implicat... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Arthritic synovial tissues from patients with rheumatoid arthritis (RA) or osteoarthritis (OA) were ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
This study identifies polymorphisms in the HIF1A and VEGF genes as potential genetic markers that in... | DisGeNET | Detail |
The role of miR-26a in atherosclerosis is mediated by its target EphA2 via a mechanism involving the... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In conclusion, CML in blast crisis had increased levels of CECs and VEGF gene expression, which may ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our evidence also suggests that the VEGF pathway and downstream NFKB signaling may explain the compl... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Biglycan up-regulated vascular endothelial growth factor (VEGF) expression and promoted angiogenesis... | DisGeNET | Detail |
Of the gene-environment combined effects, the interaction of VEGF 1451C > T and MetS contributed to ... | DisGeNET | Detail |
This study showed that Lcn2-engineered MSCs (MSC-Lcn2) not only inhibited liver metastasis of colon ... | DisGeNET | Detail |
Interleukin-1 Receptor Type 2 Acts with c-Fos to Enhance the Expression of Interleukin-6 and Vascula... | DisGeNET | Detail |
Alterations of angiogenic factors including angiotensin (AngII) or VEGF are observed in EC. | DisGeNET | Detail |
We assessed the safety and activity of dovitinib, a potent tyrosine-kinase inhibitor of fibroblast g... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Of the gene-environment combined effects, the interaction of VEGF 1451C > T and MetS contributed to ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Transient Receptor Potential Canonical 1 (TRPC1) Channels as Regulators of Sphingolipid and VEGF Rec... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The effect of Lfcin-B on non-small cell lung cancer H460 cells is mediated by inhibiting VEGF expres... | DisGeNET | Detail |
Our previous studies have found that HPV-16 oncoproteins promoted angiogenesis via enhancing hypoxia... | DisGeNET | Detail |
Retinoblastoma binding protein 2 (RBP2) promotes HIF-1α-VEGF-induced angiogenesis of non-small cell ... | DisGeNET | Detail |
EGF potentiation of VEGF production is cell density dependent in H292 EGFR wild type NSCLC cell line... | DisGeNET | Detail |
Expressions of MUC1 and vascular endothelial growth factor mRNA in blood are biomarkers for predicti... | DisGeNET | Detail |
VEGF expression was significantly higher in NSCLC tissues than in normal lung tissues. | DisGeNET | Detail |
Through Western blot analysis, we identified that E-cadherin and vascular endothelial growth factor ... | DisGeNET | Detail |
Mechanisms of and strategies for overcoming resistance to anti-vascular endothelial growth factor th... | DisGeNET | Detail |
VEGF-A Expression Correlates with TP53 Mutations in Non-Small Cell Lung Cancer: Implications for Ant... | DisGeNET | Detail |
These results suggest that low dose erlotinib-cisplatin combination exhibits its anti-tumor activity... | DisGeNET | Detail |
Prognostic impact of elevation of vascular endothelial growth factor family expression in patients w... | DisGeNET | Detail |
Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
We genotyped 70 genes involved in the pathogenesis of renal-cell carcinoma (including the VHL/HIF/VE... | DisGeNET | Detail |
Carbonic anhydrase 9 expression increases with vascular endothelial growth factor-targeted therapy a... | DisGeNET | Detail |
Predictive role of vascular endothelial growth factor polymorphisms in the survival of renal cell ca... | DisGeNET | Detail |
Several targeted therapies for advanced RCC have been approved and include sunitinib, sorafenib, paz... | DisGeNET | Detail |
The introduction of agents that inhibit tumor angiogenesis by targeting vascular endothelial growth ... | DisGeNET | Detail |
Advanced renal cell carcinoma (RCC) remains a largely incurable disease with a grave prognosis despi... | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs9513008 dbSNP
- Genome
- hg38
- Position
- chr6:43,770,211-43,786,487
- Variant Type
- snv
Genome browser